Viatris share price today
Viatris Inc. · VTRS · Healthcare · Drug Manufacturers - Specialty & Generic · price as of the 4 November 2026 close, updated every trading day · results updated weekly · All US stock lists
Viatris share price: $19.22 at the close on 4 November 2026, +89.9% in a year.
Viatris Inc.'s results are improving, and its P/E is near the top of its own history, higher than 93% of past readings.
The main question: results are strong, and the P/E is higher than 93% of its own history.
The price has been rising for 38 weeks, and the P/E is higher than 93% of its own last 2.3 years. Over the last four quarters, results have been improving, and 277% of the last 2 years' profit came in as cash. What will decide it: whether earnings grow enough to match the multiple.
What is the Viatris share price today?
Viatris Inc.'s share price was $19.22 at the close on 4 November 2026. It has been rising for 38 weeks. That is 20.2% above its average price over the last 200 trading days. In the last 52 weeks it traded between $10 and $19, and at that close it was at the high of that range.
A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Viatris Inc. is in stage 2. The phase helps read everything below.
Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 8 weeks in a row.
1Y
Nov 2026: $19.22, 20.2% above its 200-day average. The price has been rising for 38 weeks.
- Price $19.22
- 50-day avg $17.60
- 200-day avg $15.99
| Week | Price | 50-day avg | 200-day avg |
|---|---|---|---|
| 31 Oct 2025 | $10.36 | $10.13 | $9.52 |
| 7 Nov 2025 | $10.12 | $10.12 | $9.50 |
| 14 Nov 2025 | $10.72 | $10.15 | $9.48 |
| 21 Nov 2025 | $10.46 | $10.17 | $9.47 |
| 28 Nov 2025 | $10.69 | $10.25 | $9.47 |
| 5 Dec 2025 | $10.93 | $10.36 | $9.47 |
| 12 Dec 2025 | $11.65 | $10.51 | $9.48 |
| 19 Dec 2025 | $11.93 | $10.68 | $9.54 |
| 26 Dec 2025 | $12.32 | $10.86 | $9.59 |
| 2 Jan 2026 | $12.46 | $11.04 | $9.66 |
| 9 Jan 2026 | $12.76 | $11.25 | $9.74 |
| 16 Jan 2026 | $12.86 | $11.51 | $9.85 |
| 23 Jan 2026 | $13.21 | $11.73 | $9.95 |
| 30 Jan 2026 | $13.09 | $11.95 | $10.08 |
| 6 Feb 2026 | $14.58 | $12.32 | $10.25 |
| 13 Feb 2026 | $15.77 | $12.83 | $10.44 |
| 20 Feb 2026 | $15.92 | $13.23 | $10.59 |
| 27 Feb 2026 | $14.93 | $13.65 | $10.76 |
| 6 Mar 2026 | $14.16 | $13.95 | $10.91 |
| 13 Mar 2026 | $13.51 | $14.11 | $11.05 |
| 20 Mar 2026 | $13.20 | $14.22 | $11.17 |
| 27 Mar 2026 | $13.05 | $14.26 | $11.28 |
| 2 Apr 2026 | $13.44 | $14.30 | $11.37 |
| 10 Apr 2026 | $13.47 | $14.33 | $11.49 |
| 17 Apr 2026 | $14.68 | $14.38 | $11.61 |
| 24 Apr 2026 | $14.59 | $14.32 | $11.75 |
| 1 May 2026 | $15.04 | $14.22 | $11.89 |
| 8 May 2026 | $17.17 | $14.26 | $12.07 |
| 15 May 2026 | $16.48 | $14.47 | $12.27 |
| 22 May 2026 | $16.65 | $14.71 | $12.46 |
| 29 May 2026 | $16.26 | $14.92 | $12.59 |
| 5 Jun 2026 | $15.88 | $15.16 | $12.72 |
| 12 Jun 2026 | $16.48 | $15.44 | $12.85 |
| 18 Jun 2026 | $15.37 | $15.64 | $12.96 |
| 26 Jun 2026 | $16.33 | $15.86 | $13.10 |
| 2 Jul 2026 | $16.70 | $15.99 | $13.22 |
| 10 Jul 2026 | $16.27 | $16.18 | $13.39 |
| 17 Jul 2026 | $17.29 | $16.35 | $13.57 |
| 24 Jul 2026 | $17.24 | $16.38 | $13.75 |
| 31 Jul 2026 | $17.56 | $16.48 | $13.95 |
| 7 Aug 2026 | $16.43 | $16.55 | $14.12 |
| 14 Aug 2026 | $16.23 | $16.58 | $14.27 |
| 21 Aug 2026 | $16.32 | $16.60 | $14.42 |
| 28 Aug 2026 | $16.34 | $16.65 | $14.57 |
| 4 Sep 2026 | $16.88 | $16.76 | $14.72 |
| 11 Sep 2026 | $16.51 | $16.79 | $14.84 |
| 18 Sep 2026 | $16.95 | $16.81 | $15.00 |
| 25 Sep 2026 | $17.83 | $16.88 | $15.16 |
| 2 Oct 2026 | $17.60 | $16.94 | $15.32 |
| 9 Oct 2026 | $17.64 | $16.93 | $15.46 |
| 16 Oct 2026 | $18.66 | $16.98 | $15.60 |
| 23 Oct 2026 | $18.00 | $17.19 | $15.75 |
| 30 Oct 2026 | $19.04 | $17.45 | $15.90 |
| 4 Nov 2026 | $19.22 | $17.60 | $15.99 |
3Y
Nov 2026: $19.22, 20.2% above its 200-day average. The price has been rising for 38 weeks.
- Price $19.22
- 50-day avg $17.60
- 200-day avg $15.99
| Week | Price | 50-day avg | 200-day avg |
|---|---|---|---|
| 3 Nov 2023 | $9.27 | $9.72 | $10.14 |
| 10 Nov 2023 | $9.20 | $9.55 | $10.08 |
| 17 Nov 2023 | $9.45 | $9.44 | $10.01 |
| 24 Nov 2023 | $9.43 | $9.40 | $9.95 |
| 1 Dec 2023 | $9.37 | $9.34 | $9.89 |
| 8 Dec 2023 | $9.83 | $9.34 | $9.84 |
| 15 Dec 2023 | $10.27 | $9.38 | $9.81 |
| 22 Dec 2023 | $10.65 | $9.46 | $9.81 |
| 29 Dec 2023 | $10.83 | $9.57 | $9.83 |
| 5 Jan 2024 | $11.98 | $9.76 | $9.87 |
| 12 Jan 2024 | $11.68 | $10.06 | $9.93 |
| 19 Jan 2024 | $11.40 | $10.25 | $9.97 |
| 26 Jan 2024 | $11.93 | $10.51 | $10.01 |
| 2 Feb 2024 | $11.85 | $10.76 | $10.06 |
| 9 Feb 2024 | $11.68 | $11.00 | $10.12 |
| 16 Feb 2024 | $13.06 | $11.30 | $10.20 |
| 23 Feb 2024 | $13.53 | $11.58 | $10.28 |
| 1 Mar 2024 | $12.59 | $11.84 | $10.36 |
| 8 Mar 2024 | $12.26 | $12.02 | $10.43 |
| 15 Mar 2024 | $11.94 | $12.11 | $10.51 |
| 22 Mar 2024 | $11.84 | $12.12 | $10.57 |
| 28 Mar 2024 | $11.94 | $12.12 | $10.62 |
| 5 Apr 2024 | $11.80 | $12.16 | $10.66 |
| 12 Apr 2024 | $11.33 | $12.14 | $10.71 |
| 19 Apr 2024 | $11.25 | $12.08 | $10.74 |
| 26 Apr 2024 | $11.57 | $12.04 | $10.77 |
| 3 May 2024 | $11.78 | $11.89 | $10.81 |
| 10 May 2024 | $11.16 | $11.75 | $10.84 |
| 17 May 2024 | $10.98 | $11.62 | $10.86 |
| 24 May 2024 | $10.41 | $11.50 | $10.85 |
| 31 May 2024 | $10.60 | $11.38 | $10.84 |
| 7 Jun 2024 | $10.47 | $11.25 | $10.82 |
| 14 Jun 2024 | $10.17 | $11.10 | $10.81 |
| 21 Jun 2024 | $10.47 | $10.98 | $10.79 |
| 28 Jun 2024 | $10.63 | $10.90 | $10.81 |
| 5 Jul 2024 | $10.32 | $10.83 | $10.82 |
| 12 Jul 2024 | $11.24 | $10.77 | $10.85 |
| 19 Jul 2024 | $11.84 | $10.75 | $10.89 |
| 26 Jul 2024 | $12.08 | $10.79 | $10.94 |
| 2 Aug 2024 | $11.87 | $10.89 | $11.01 |
| 9 Aug 2024 | $11.78 | $11.00 | $11.06 |
| 16 Aug 2024 | $11.66 | $11.11 | $11.13 |
| 23 Aug 2024 | $11.76 | $11.23 | $11.20 |
| 30 Aug 2024 | $12.08 | $11.39 | $11.27 |
| 6 Sep 2024 | $11.27 | $11.49 | $11.31 |
| 13 Sep 2024 | $11.66 | $11.58 | $11.36 |
| 20 Sep 2024 | $11.39 | $11.68 | $11.43 |
| 27 Sep 2024 | $11.55 | $11.69 | $11.47 |
| 4 Oct 2024 | $11.59 | $11.67 | $11.50 |
| 11 Oct 2024 | $11.38 | $11.60 | $11.52 |
| 18 Oct 2024 | $11.76 | $11.61 | $11.54 |
| 25 Oct 2024 | $11.44 | $11.60 | $11.53 |
| 1 Nov 2024 | $11.62 | $11.60 | $11.53 |
| 8 Nov 2024 | $12.96 | $11.64 | $11.55 |
| 15 Nov 2024 | $12.83 | $11.75 | $11.57 |
| 22 Nov 2024 | $13.37 | $11.93 | $11.61 |
| 29 Nov 2024 | $13.09 | $12.04 | $11.63 |
| 6 Dec 2024 | $12.72 | $12.19 | $11.63 |
| 13 Dec 2024 | $12.63 | $12.31 | $11.62 |
| 20 Dec 2024 | $12.52 | $12.41 | $11.62 |
| 27 Dec 2024 | $12.48 | $12.48 | $11.63 |
| 3 Jan 2025 | $12.28 | $12.54 | $11.64 |
| 10 Jan 2025 | $11.67 | $12.56 | $11.64 |
| 17 Jan 2025 | $11.30 | $12.55 | $11.63 |
| 24 Jan 2025 | $11.20 | $12.46 | $11.62 |
| 31 Jan 2025 | $11.28 | $12.30 | $11.62 |
| 7 Feb 2025 | $10.73 | $12.07 | $11.61 |
| 14 Feb 2025 | $10.80 | $11.82 | $11.59 |
| 21 Feb 2025 | $11.25 | $11.67 | $11.58 |
| 28 Feb 2025 | $9.23 | $11.46 | $11.55 |
| 7 Mar 2025 | $9.65 | $11.17 | $11.51 |
| 14 Mar 2025 | $9.10 | $10.84 | $11.47 |
| 21 Mar 2025 | $9.15 | $10.56 | $11.44 |
| 28 Mar 2025 | $8.68 | $10.28 | $11.41 |
| 4 Apr 2025 | $7.62 | $9.99 | $11.35 |
| 11 Apr 2025 | $7.54 | $9.61 | $11.28 |
| 17 Apr 2025 | $7.56 | $9.33 | $11.22 |
| 25 Apr 2025 | $8.13 | $9.04 | $11.16 |
| 2 May 2025 | $8.65 | $8.80 | $11.09 |
| 9 May 2025 | $8.77 | $8.57 | $11.01 |
| 16 May 2025 | $8.84 | $8.51 | $10.94 |
| 23 May 2025 | $8.29 | $8.43 | $10.86 |
| 30 May 2025 | $8.79 | $8.38 | $10.80 |
| 6 Jun 2025 | $8.71 | $8.33 | $10.72 |
| 13 Jun 2025 | $8.92 | $8.36 | $10.65 |
| 20 Jun 2025 | $8.87 | $8.45 | $10.59 |
| 27 Jun 2025 | $9.01 | $8.59 | $10.53 |
| 3 Jul 2025 | $9.32 | $8.72 | $10.48 |
| 11 Jul 2025 | $9.12 | $8.83 | $10.42 |
| 18 Jul 2025 | $8.88 | $8.89 | $10.36 |
| 25 Jul 2025 | $9.41 | $8.93 | $10.30 |
| 1 Aug 2025 | $8.81 | $8.95 | $10.24 |
| 8 Aug 2025 | $9.70 | $9.02 | $10.18 |
| 15 Aug 2025 | $10.61 | $9.18 | $10.15 |
| 22 Aug 2025 | $10.65 | $9.37 | $10.12 |
| 29 Aug 2025 | $10.55 | $9.52 | $10.08 |
| 5 Sep 2025 | $10.50 | $9.65 | $10.03 |
| 12 Sep 2025 | $9.96 | $9.77 | $9.96 |
| 19 Sep 2025 | $9.90 | $9.81 | $9.87 |
| 26 Sep 2025 | $9.52 | $9.86 | $9.79 |
| 3 Oct 2025 | $10.19 | $9.95 | $9.72 |
| 10 Oct 2025 | $9.74 | $10.03 | $9.66 |
| 17 Oct 2025 | $10.17 | $10.14 | $9.60 |
| 24 Oct 2025 | $10.35 | $10.16 | $9.55 |
| 31 Oct 2025 | $10.36 | $10.13 | $9.52 |
| 7 Nov 2025 | $10.12 | $10.12 | $9.50 |
| 14 Nov 2025 | $10.72 | $10.15 | $9.48 |
| 21 Nov 2025 | $10.46 | $10.17 | $9.47 |
| 28 Nov 2025 | $10.69 | $10.25 | $9.47 |
| 5 Dec 2025 | $10.93 | $10.36 | $9.47 |
| 12 Dec 2025 | $11.65 | $10.51 | $9.48 |
| 19 Dec 2025 | $11.93 | $10.68 | $9.54 |
| 26 Dec 2025 | $12.32 | $10.86 | $9.59 |
| 2 Jan 2026 | $12.46 | $11.04 | $9.66 |
| 9 Jan 2026 | $12.76 | $11.25 | $9.74 |
| 16 Jan 2026 | $12.86 | $11.51 | $9.85 |
| 23 Jan 2026 | $13.21 | $11.73 | $9.95 |
| 30 Jan 2026 | $13.09 | $11.95 | $10.08 |
| 6 Feb 2026 | $14.58 | $12.32 | $10.25 |
| 13 Feb 2026 | $15.77 | $12.83 | $10.44 |
| 20 Feb 2026 | $15.92 | $13.23 | $10.59 |
| 27 Feb 2026 | $14.93 | $13.65 | $10.76 |
| 6 Mar 2026 | $14.16 | $13.95 | $10.91 |
| 13 Mar 2026 | $13.51 | $14.11 | $11.05 |
| 20 Mar 2026 | $13.20 | $14.22 | $11.17 |
| 27 Mar 2026 | $13.05 | $14.26 | $11.28 |
| 2 Apr 2026 | $13.44 | $14.30 | $11.37 |
| 10 Apr 2026 | $13.47 | $14.33 | $11.49 |
| 17 Apr 2026 | $14.68 | $14.38 | $11.61 |
| 24 Apr 2026 | $14.59 | $14.32 | $11.75 |
| 1 May 2026 | $15.04 | $14.22 | $11.89 |
| 8 May 2026 | $17.17 | $14.26 | $12.07 |
| 15 May 2026 | $16.48 | $14.47 | $12.27 |
| 22 May 2026 | $16.65 | $14.71 | $12.46 |
| 29 May 2026 | $16.26 | $14.92 | $12.59 |
| 5 Jun 2026 | $15.88 | $15.16 | $12.72 |
| 12 Jun 2026 | $16.48 | $15.44 | $12.85 |
| 18 Jun 2026 | $15.37 | $15.64 | $12.96 |
| 26 Jun 2026 | $16.33 | $15.86 | $13.10 |
| 2 Jul 2026 | $16.70 | $15.99 | $13.22 |
| 10 Jul 2026 | $16.27 | $16.18 | $13.39 |
| 17 Jul 2026 | $17.29 | $16.35 | $13.57 |
| 24 Jul 2026 | $17.24 | $16.38 | $13.75 |
| 31 Jul 2026 | $17.56 | $16.48 | $13.95 |
| 7 Aug 2026 | $16.43 | $16.55 | $14.12 |
| 14 Aug 2026 | $16.23 | $16.58 | $14.27 |
| 21 Aug 2026 | $16.32 | $16.60 | $14.42 |
| 28 Aug 2026 | $16.34 | $16.65 | $14.57 |
| 4 Sep 2026 | $16.88 | $16.76 | $14.72 |
| 11 Sep 2026 | $16.51 | $16.79 | $14.84 |
| 18 Sep 2026 | $16.95 | $16.81 | $15.00 |
| 25 Sep 2026 | $17.83 | $16.88 | $15.16 |
| 2 Oct 2026 | $17.60 | $16.94 | $15.32 |
| 9 Oct 2026 | $17.64 | $16.93 | $15.46 |
| 16 Oct 2026 | $18.66 | $16.98 | $15.60 |
| 23 Oct 2026 | $18.00 | $17.19 | $15.75 |
| 30 Oct 2026 | $19.04 | $17.45 | $15.90 |
| 4 Nov 2026 | $19.22 | $17.60 | $15.99 |
5Y
Nov 2026: $19.22, 20.2% above its 200-day average. The price has been rising for 38 weeks.
- Price $19.22
- 50-day avg $17.60
- 200-day avg $15.99
| Week | Price | 50-day avg | 200-day avg |
|---|---|---|---|
| 29 Oct 2021 | $13.35 | $13.86 | $14.67 |
| 12 Nov 2021 | $14.11 | $13.77 | $14.52 |
| 26 Nov 2021 | $12.75 | $13.62 | $14.31 |
| 10 Dec 2021 | $12.70 | $13.40 | $14.09 |
| 23 Dec 2021 | $13.63 | $13.30 | $14.04 |
| 7 Jan 2022 | $14.74 | $13.38 | $14.02 |
| 21 Jan 2022 | $14.53 | $13.57 | $14.06 |
| 4 Feb 2022 | $15.13 | $13.80 | $14.14 |
| 18 Feb 2022 | $14.71 | $14.34 | $14.23 |
| 4 Mar 2022 | $10.20 | $14.23 | $14.08 |
| 18 Mar 2022 | $10.66 | $13.51 | $13.82 |
| 1 Apr 2022 | $10.82 | $12.71 | $13.60 |
| 14 Apr 2022 | $10.96 | $12.00 | $13.44 |
| 29 Apr 2022 | $10.33 | $11.06 | $13.26 |
| 13 May 2022 | $11.08 | $10.57 | $13.08 |
| 27 May 2022 | $12.25 | $10.87 | $12.94 |
| 10 Jun 2022 | $11.20 | $11.04 | $12.81 |
| 24 Jun 2022 | $10.96 | $11.00 | $12.63 |
| 8 Jul 2022 | $10.35 | $10.99 | $12.49 |
| 22 Jul 2022 | $9.55 | $10.91 | $12.31 |
| 5 Aug 2022 | $9.73 | $10.61 | $12.12 |
| 19 Aug 2022 | $10.57 | $10.36 | $11.98 |
| 2 Sep 2022 | $9.45 | $10.19 | $11.76 |
| 16 Sep 2022 | $9.30 | $10.00 | $11.61 |
| 30 Sep 2022 | $8.52 | $9.76 | $11.43 |
| 14 Oct 2022 | $9.55 | $9.64 | $11.23 |
| 28 Oct 2022 | $10.07 | $9.44 | $10.98 |
| 11 Nov 2022 | $11.44 | $9.55 | $10.77 |
| 25 Nov 2022 | $11.14 | $9.82 | $10.59 |
| 9 Dec 2022 | $10.78 | $10.25 | $10.40 |
| 23 Dec 2022 | $11.01 | $10.64 | $10.42 |
| 6 Jan 2023 | $12.10 | $10.95 | $10.46 |
| 20 Jan 2023 | $11.60 | $11.24 | $10.49 |
| 3 Feb 2023 | $12.18 | $11.39 | $10.55 |
| 17 Feb 2023 | $11.69 | $11.55 | $10.62 |
| 3 Mar 2023 | $11.13 | $11.60 | $10.66 |
| 17 Mar 2023 | $9.43 | $11.39 | $10.57 |
| 31 Mar 2023 | $9.62 | $10.94 | $10.47 |
| 14 Apr 2023 | $9.87 | $10.57 | $10.43 |
| 28 Apr 2023 | $9.33 | $10.08 | $10.38 |
| 12 May 2023 | $9.28 | $9.67 | $10.36 |
| 26 May 2023 | $9.11 | $9.47 | $10.32 |
| 9 Jun 2023 | $9.38 | $9.46 | $10.26 |
| 23 Jun 2023 | $9.76 | $9.49 | $10.27 |
| 7 Jul 2023 | $9.86 | $9.52 | $10.28 |
| 21 Jul 2023 | $10.48 | $9.71 | $10.36 |
| 4 Aug 2023 | $10.59 | $9.93 | $10.42 |
| 18 Aug 2023 | $11.26 | $10.32 | $10.49 |
| 1 Sep 2023 | $10.79 | $10.55 | $10.51 |
| 15 Sep 2023 | $9.77 | $10.57 | $10.46 |
| 29 Sep 2023 | $9.86 | $10.49 | $10.40 |
| 13 Oct 2023 | $9.33 | $10.33 | $10.33 |
| 27 Oct 2023 | $8.77 | $9.94 | $10.21 |
| 10 Nov 2023 | $9.20 | $9.55 | $10.08 |
| 24 Nov 2023 | $9.43 | $9.40 | $9.95 |
| 8 Dec 2023 | $9.83 | $9.34 | $9.84 |
| 22 Dec 2023 | $10.65 | $9.46 | $9.81 |
| 5 Jan 2024 | $11.98 | $9.76 | $9.87 |
| 19 Jan 2024 | $11.40 | $10.25 | $9.97 |
| 2 Feb 2024 | $11.85 | $10.76 | $10.06 |
| 16 Feb 2024 | $13.06 | $11.30 | $10.20 |
| 1 Mar 2024 | $12.59 | $11.84 | $10.36 |
| 15 Mar 2024 | $11.94 | $12.11 | $10.51 |
| 28 Mar 2024 | $11.94 | $12.12 | $10.62 |
| 12 Apr 2024 | $11.33 | $12.14 | $10.71 |
| 26 Apr 2024 | $11.57 | $12.04 | $10.77 |
| 10 May 2024 | $11.16 | $11.75 | $10.84 |
| 24 May 2024 | $10.41 | $11.50 | $10.85 |
| 7 Jun 2024 | $10.47 | $11.25 | $10.82 |
| 21 Jun 2024 | $10.47 | $10.98 | $10.79 |
| 5 Jul 2024 | $10.32 | $10.83 | $10.82 |
| 19 Jul 2024 | $11.84 | $10.75 | $10.89 |
| 2 Aug 2024 | $11.87 | $10.89 | $11.01 |
| 16 Aug 2024 | $11.66 | $11.11 | $11.13 |
| 30 Aug 2024 | $12.08 | $11.39 | $11.27 |
| 13 Sep 2024 | $11.66 | $11.58 | $11.36 |
| 27 Sep 2024 | $11.55 | $11.69 | $11.47 |
| 11 Oct 2024 | $11.38 | $11.60 | $11.52 |
| 25 Oct 2024 | $11.44 | $11.60 | $11.53 |
| 8 Nov 2024 | $12.96 | $11.64 | $11.55 |
| 22 Nov 2024 | $13.37 | $11.93 | $11.61 |
| 6 Dec 2024 | $12.72 | $12.19 | $11.63 |
| 20 Dec 2024 | $12.52 | $12.41 | $11.62 |
| 3 Jan 2025 | $12.28 | $12.54 | $11.64 |
| 17 Jan 2025 | $11.30 | $12.55 | $11.63 |
| 31 Jan 2025 | $11.28 | $12.30 | $11.62 |
| 14 Feb 2025 | $10.80 | $11.82 | $11.59 |
| 28 Feb 2025 | $9.23 | $11.46 | $11.55 |
| 14 Mar 2025 | $9.10 | $10.84 | $11.47 |
| 28 Mar 2025 | $8.68 | $10.28 | $11.41 |
| 11 Apr 2025 | $7.54 | $9.61 | $11.28 |
| 25 Apr 2025 | $8.13 | $9.04 | $11.16 |
| 9 May 2025 | $8.77 | $8.57 | $11.01 |
| 23 May 2025 | $8.29 | $8.43 | $10.86 |
| 6 Jun 2025 | $8.71 | $8.33 | $10.72 |
| 20 Jun 2025 | $8.87 | $8.45 | $10.59 |
| 3 Jul 2025 | $9.32 | $8.72 | $10.48 |
| 18 Jul 2025 | $8.88 | $8.89 | $10.36 |
| 1 Aug 2025 | $8.81 | $8.95 | $10.24 |
| 15 Aug 2025 | $10.61 | $9.18 | $10.15 |
| 29 Aug 2025 | $10.55 | $9.52 | $10.08 |
| 12 Sep 2025 | $9.96 | $9.77 | $9.96 |
| 26 Sep 2025 | $9.52 | $9.86 | $9.79 |
| 10 Oct 2025 | $9.74 | $10.03 | $9.66 |
| 24 Oct 2025 | $10.35 | $10.16 | $9.55 |
| 7 Nov 2025 | $10.12 | $10.12 | $9.50 |
| 21 Nov 2025 | $10.46 | $10.17 | $9.47 |
| 5 Dec 2025 | $10.93 | $10.36 | $9.47 |
| 19 Dec 2025 | $11.93 | $10.68 | $9.54 |
| 2 Jan 2026 | $12.46 | $11.04 | $9.66 |
| 16 Jan 2026 | $12.86 | $11.51 | $9.85 |
| 30 Jan 2026 | $13.09 | $11.95 | $10.08 |
| 13 Feb 2026 | $15.77 | $12.83 | $10.44 |
| 27 Feb 2026 | $14.93 | $13.65 | $10.76 |
| 13 Mar 2026 | $13.51 | $14.11 | $11.05 |
| 27 Mar 2026 | $13.05 | $14.26 | $11.28 |
| 10 Apr 2026 | $13.47 | $14.33 | $11.49 |
| 24 Apr 2026 | $14.59 | $14.32 | $11.75 |
| 8 May 2026 | $17.17 | $14.26 | $12.07 |
| 22 May 2026 | $16.65 | $14.71 | $12.46 |
| 5 Jun 2026 | $15.88 | $15.16 | $12.72 |
| 18 Jun 2026 | $15.37 | $15.64 | $12.96 |
| 2 Jul 2026 | $16.70 | $15.99 | $13.22 |
| 17 Jul 2026 | $17.29 | $16.35 | $13.57 |
| 31 Jul 2026 | $17.56 | $16.48 | $13.95 |
| 14 Aug 2026 | $16.23 | $16.58 | $14.27 |
| 28 Aug 2026 | $16.34 | $16.65 | $14.57 |
| 11 Sep 2026 | $16.51 | $16.79 | $14.84 |
| 25 Sep 2026 | $17.83 | $16.88 | $15.16 |
| 9 Oct 2026 | $17.64 | $16.93 | $15.46 |
| 23 Oct 2026 | $18.00 | $17.19 | $15.75 |
| 4 Nov 2026 | $19.22 | $17.60 | $15.99 |
10Y
Nov 2026: $19.22, 20.2% above its 200-day average. The price has been rising for 38 weeks.
- Price $19.22
- 50-day avg $17.60
- 200-day avg $15.99
| Week | Price | 50-day avg | 200-day avg |
|---|---|---|---|
| 28 Oct 2016 | $37.19 | $40.17 | – |
| 18 Nov 2016 | $36.47 | $38.46 | – |
| 9 Dec 2016 | $36.51 | $37.06 | – |
| 30 Dec 2016 | $38.15 | $37.08 | – |
| 20 Jan 2017 | $37.07 | $37.35 | – |
| 10 Feb 2017 | $39.31 | $37.52 | – |
| 3 Mar 2017 | $45.18 | $39.16 | – |
| 24 Mar 2017 | $40.96 | $40.51 | – |
| 13 Apr 2017 | $37.67 | $41.21 | – |
| 5 May 2017 | $37.90 | $40.25 | $40.07 |
| 26 May 2017 | $39.72 | $38.87 | $39.41 |
| 16 Jun 2017 | $36.72 | $38.32 | $38.87 |
| 7 Jul 2017 | $37.61 | $38.49 | $38.68 |
| 28 Jul 2017 | $38.74 | $38.65 | $38.63 |
| 18 Aug 2017 | $30.72 | $36.77 | $38.29 |
| 8 Sep 2017 | $32.10 | $34.76 | $37.87 |
| 29 Sep 2017 | $31.37 | $32.78 | $37.53 |
| 20 Oct 2017 | $38.51 | $33.13 | $37.49 |
| 10 Nov 2017 | $38.16 | $35.22 | $37.52 |
| 1 Dec 2017 | $38.12 | $36.66 | $37.36 |
| 22 Dec 2017 | $42.05 | $38.16 | $37.10 |
| 12 Jan 2018 | $46.90 | $39.64 | $37.22 |
| 2 Feb 2018 | $42.10 | $41.99 | $37.72 |
| 23 Feb 2018 | $41.45 | $42.94 | $37.95 |
| 16 Mar 2018 | $41.73 | $43.04 | $38.17 |
| 6 Apr 2018 | $39.52 | $41.44 | $38.29 |
| 27 Apr 2018 | $39.34 | $40.91 | $38.44 |
| 18 May 2018 | $39.66 | $39.78 | $38.37 |
| 8 Jun 2018 | $41.36 | $39.37 | $38.94 |
| 29 Jun 2018 | $36.14 | $38.86 | $39.49 |
| 20 Jul 2018 | $35.53 | $38.34 | $39.81 |
| 10 Aug 2018 | $37.21 | $37.76 | $39.73 |
| 31 Aug 2018 | $39.13 | $37.35 | $39.82 |
| 21 Sep 2018 | $38.99 | $37.73 | $39.89 |
| 12 Oct 2018 | $32.11 | $37.57 | $39.56 |
| 2 Nov 2018 | $31.68 | $35.70 | $38.58 |
| 23 Nov 2018 | $33.49 | $34.66 | $37.97 |
| 14 Dec 2018 | $29.05 | $33.11 | $37.34 |
| 4 Jan 2019 | $28.84 | $31.59 | $36.41 |
| 25 Jan 2019 | $29.04 | $30.54 | $35.64 |
| 15 Feb 2019 | $31.84 | $29.45 | $34.92 |
| 8 Mar 2019 | $26.61 | $29.32 | $34.30 |
| 29 Mar 2019 | $28.34 | $29.19 | $33.42 |
| 18 Apr 2019 | $26.85 | $28.53 | $32.65 |
| 10 May 2019 | $22.17 | $27.10 | $31.87 |
| 31 May 2019 | $16.80 | $24.71 | $30.59 |
| 21 Jun 2019 | $18.32 | $21.60 | $29.02 |
| 12 Jul 2019 | $19.22 | $19.42 | $27.68 |
| 2 Aug 2019 | $19.84 | $18.52 | $26.46 |
| 23 Aug 2019 | $18.34 | $18.87 | $25.48 |
| 13 Sep 2019 | $21.69 | $19.40 | $24.45 |
| 4 Oct 2019 | $18.91 | $19.81 | $23.60 |
| 25 Oct 2019 | $18.70 | $19.56 | $22.89 |
| 15 Nov 2019 | $17.70 | $19.25 | $22.06 |
| 6 Dec 2019 | $19.29 | $18.40 | $21.15 |
| 27 Dec 2019 | $19.72 | $18.54 | $20.56 |
| 17 Jan 2020 | $21.66 | $19.14 | $20.05 |
| 7 Feb 2020 | $22.77 | $20.43 | $19.70 |
| 28 Feb 2020 | $17.19 | $20.96 | $19.41 |
| 20 Mar 2020 | $15.25 | $19.55 | $19.16 |
| 9 Apr 2020 | $16.08 | $17.66 | $18.96 |
| 1 May 2020 | $16.13 | $15.86 | $18.72 |
| 22 May 2020 | $15.64 | $15.63 | $18.51 |
| 12 Jun 2020 | $15.94 | $16.27 | $18.40 |
| 2 Jul 2020 | $15.93 | $16.52 | $18.07 |
| 24 Jul 2020 | $15.96 | $16.48 | $17.82 |
| 14 Aug 2020 | $16.19 | $16.42 | $17.65 |
| 4 Sep 2020 | $15.81 | $16.25 | $17.52 |
| 25 Sep 2020 | $14.42 | $15.98 | $17.29 |
| 16 Oct 2020 | $15.71 | $15.62 | $16.97 |
| 6 Nov 2020 | $14.65 | $15.24 | $16.50 |
| 27 Nov 2020 | $17.05 | $15.41 | $16.09 |
| 18 Dec 2020 | $17.75 | $16.20 | $15.98 |
| 8 Jan 2021 | $18.30 | $16.89 | $16.20 |
| 29 Jan 2021 | $16.99 | $17.55 | $16.37 |
| 19 Feb 2021 | $18.21 | $17.84 | $16.51 |
| 12 Mar 2021 | $14.36 | $16.87 | $16.37 |
| 1 Apr 2021 | $13.90 | $15.83 | $16.18 |
| 23 Apr 2021 | $13.36 | $14.56 | $15.97 |
| 14 May 2021 | $16.00 | $13.99 | $15.80 |
| 4 Jun 2021 | $15.39 | $14.29 | $15.74 |
| 25 Jun 2021 | $14.57 | $14.67 | $15.66 |
| 16 Jul 2021 | $13.76 | $14.90 | $15.60 |
| 6 Aug 2021 | $14.25 | $14.51 | $15.50 |
| 27 Aug 2021 | $14.37 | $14.32 | $15.48 |
| 17 Sep 2021 | $13.57 | $14.30 | $15.32 |
| 8 Oct 2021 | $13.63 | $14.16 | $15.01 |
| 29 Oct 2021 | $13.35 | $13.86 | $14.67 |
| 19 Nov 2021 | $13.08 | $13.68 | $14.41 |
| 10 Dec 2021 | $12.70 | $13.40 | $14.09 |
| 31 Dec 2021 | $13.53 | $13.30 | $14.01 |
| 21 Jan 2022 | $14.53 | $13.57 | $14.06 |
| 11 Feb 2022 | $15.17 | $14.07 | $14.19 |
| 4 Mar 2022 | $10.20 | $14.23 | $14.08 |
| 25 Mar 2022 | $11.19 | $13.10 | $13.71 |
| 14 Apr 2022 | $10.96 | $12.00 | $13.44 |
| 6 May 2022 | $9.95 | $10.63 | $13.17 |
| 27 May 2022 | $12.25 | $10.87 | $12.94 |
| 17 Jun 2022 | $10.46 | $11.01 | $12.71 |
| 8 Jul 2022 | $10.35 | $10.99 | $12.49 |
| 29 Jul 2022 | $9.69 | $10.80 | $12.22 |
| 19 Aug 2022 | $10.57 | $10.36 | $11.98 |
| 9 Sep 2022 | $9.88 | $10.09 | $11.69 |
| 30 Sep 2022 | $8.52 | $9.76 | $11.43 |
| 21 Oct 2022 | $9.38 | $9.55 | $11.11 |
| 11 Nov 2022 | $11.44 | $9.55 | $10.77 |
| 2 Dec 2022 | $11.17 | $10.02 | $10.49 |
| 23 Dec 2022 | $11.01 | $10.64 | $10.42 |
| 13 Jan 2023 | $11.54 | $11.12 | $10.48 |
| 3 Feb 2023 | $12.18 | $11.39 | $10.55 |
| 24 Feb 2023 | $11.51 | $11.59 | $10.65 |
| 17 Mar 2023 | $9.43 | $11.39 | $10.57 |
| 6 Apr 2023 | $9.92 | $10.78 | $10.45 |
| 28 Apr 2023 | $9.33 | $10.08 | $10.38 |
| 19 May 2023 | $9.33 | $9.53 | $10.35 |
| 9 Jun 2023 | $9.38 | $9.46 | $10.26 |
| 30 Jun 2023 | $9.98 | $9.49 | $10.27 |
| 21 Jul 2023 | $10.48 | $9.71 | $10.36 |
| 11 Aug 2023 | $11.35 | $10.13 | $10.46 |
| 1 Sep 2023 | $10.79 | $10.55 | $10.51 |
| 22 Sep 2023 | $9.64 | $10.54 | $10.43 |
| 13 Oct 2023 | $9.33 | $10.33 | $10.33 |
| 3 Nov 2023 | $9.27 | $9.72 | $10.14 |
| 24 Nov 2023 | $9.43 | $9.40 | $9.95 |
| 15 Dec 2023 | $10.27 | $9.38 | $9.81 |
| 5 Jan 2024 | $11.98 | $9.76 | $9.87 |
| 26 Jan 2024 | $11.93 | $10.51 | $10.01 |
| 16 Feb 2024 | $13.06 | $11.30 | $10.20 |
| 8 Mar 2024 | $12.26 | $12.02 | $10.43 |
| 28 Mar 2024 | $11.94 | $12.12 | $10.62 |
| 19 Apr 2024 | $11.25 | $12.08 | $10.74 |
| 10 May 2024 | $11.16 | $11.75 | $10.84 |
| 31 May 2024 | $10.60 | $11.38 | $10.84 |
| 21 Jun 2024 | $10.47 | $10.98 | $10.79 |
| 12 Jul 2024 | $11.24 | $10.77 | $10.85 |
| 2 Aug 2024 | $11.87 | $10.89 | $11.01 |
| 23 Aug 2024 | $11.76 | $11.23 | $11.20 |
| 13 Sep 2024 | $11.66 | $11.58 | $11.36 |
| 4 Oct 2024 | $11.59 | $11.67 | $11.50 |
| 25 Oct 2024 | $11.44 | $11.60 | $11.53 |
| 15 Nov 2024 | $12.83 | $11.75 | $11.57 |
| 6 Dec 2024 | $12.72 | $12.19 | $11.63 |
| 27 Dec 2024 | $12.48 | $12.48 | $11.63 |
| 17 Jan 2025 | $11.30 | $12.55 | $11.63 |
| 7 Feb 2025 | $10.73 | $12.07 | $11.61 |
| 28 Feb 2025 | $9.23 | $11.46 | $11.55 |
| 21 Mar 2025 | $9.15 | $10.56 | $11.44 |
| 11 Apr 2025 | $7.54 | $9.61 | $11.28 |
| 2 May 2025 | $8.65 | $8.80 | $11.09 |
| 23 May 2025 | $8.29 | $8.43 | $10.86 |
| 13 Jun 2025 | $8.92 | $8.36 | $10.65 |
| 3 Jul 2025 | $9.32 | $8.72 | $10.48 |
| 25 Jul 2025 | $9.41 | $8.93 | $10.30 |
| 15 Aug 2025 | $10.61 | $9.18 | $10.15 |
| 5 Sep 2025 | $10.50 | $9.65 | $10.03 |
| 26 Sep 2025 | $9.52 | $9.86 | $9.79 |
| 17 Oct 2025 | $10.17 | $10.14 | $9.60 |
| 7 Nov 2025 | $10.12 | $10.12 | $9.50 |
| 28 Nov 2025 | $10.69 | $10.25 | $9.47 |
| 19 Dec 2025 | $11.93 | $10.68 | $9.54 |
| 9 Jan 2026 | $12.76 | $11.25 | $9.74 |
| 30 Jan 2026 | $13.09 | $11.95 | $10.08 |
| 20 Feb 2026 | $15.92 | $13.23 | $10.59 |
| 13 Mar 2026 | $13.51 | $14.11 | $11.05 |
| 2 Apr 2026 | $13.44 | $14.30 | $11.37 |
| 24 Apr 2026 | $14.59 | $14.32 | $11.75 |
| 15 May 2026 | $16.48 | $14.47 | $12.27 |
| 5 Jun 2026 | $15.88 | $15.16 | $12.72 |
| 26 Jun 2026 | $16.33 | $15.86 | $13.10 |
| 17 Jul 2026 | $17.29 | $16.35 | $13.57 |
| 7 Aug 2026 | $16.43 | $16.55 | $14.12 |
| 28 Aug 2026 | $16.34 | $16.65 | $14.57 |
| 18 Sep 2026 | $16.95 | $16.81 | $15.00 |
| 9 Oct 2026 | $17.64 | $16.93 | $15.46 |
| 30 Oct 2026 | $19.04 | $17.45 | $15.90 |
| 4 Nov 2026 | $19.22 | $17.60 | $15.99 |
Price stage: Sideways from Oct 2025 to Feb 2026; Rising from Feb 2026 to Nov 2026.
Price stage: Falling from Nov 2023 to Dec 2023; Sideways from Dec 2023 to Mar 2024; Rising from Mar 2024 to May 2024; Sideways from May 2024 to Jul 2024; Rising from Jul 2024 to Jan 2025; Sideways from Jan 2025 to Apr 2025; Falling from Apr 2025 to Aug 2025; Sideways from Aug 2025 to Feb 2026; Rising from Feb 2026 to Nov 2026.
Price stage: Falling from Oct 2021 to Dec 2021; Sideways from Jan 2022 to Feb 2022; Falling from Mar 2022 to Oct 2022; Sideways from Nov 2022 to Mar 2023; Falling from Mar 2023 to Jul 2023; Sideways from Jul 2023 to Sep 2023; Falling from Sep 2023 to Dec 2023; Sideways from Dec 2023 to Mar 2024; Rising from Mar 2024 to May 2024; Sideways from May 2024 to Jul 2024; Rising from Jul 2024 to Jan 2025; Sideways from Jan 2025 to Apr 2025; Falling from Apr 2025 to Sep 2025; Sideways from Oct 2025 to Feb 2026; Rising from Feb 2026 to Nov 2026.
Price stage: Sideways from Dec 2017 to Mar 2018; Rising from Apr 2018 to Jun 2018; Sideways from Jun 2018 to Nov 2018; Falling from Nov 2018 to Nov 2020; Sideways from Nov 2020 to Feb 2021; Falling from Mar 2021 to Oct 2022; Sideways from Nov 2022 to Feb 2023; Falling from Mar 2023 to Jun 2023; Sideways from Jul 2023 to Sep 2023; Falling from Sep 2023 to Nov 2023; Sideways from Dec 2023 to Mar 2024; Rising from Mar 2024 to Dec 2024; Sideways from Jan 2025 to Apr 2025; Falling from May 2025 to Sep 2025; Sideways from Oct 2025 to Jan 2026; Rising from Feb 2026 to Nov 2026.
Week by week since 2016: did it beat the S&P 500 over the past 13 weeks?
Ahead in 193 of 527 weeks
| Week | 13-week return vs S&P 500 |
|---|---|
| 8 Jul 2016 | no S&P 500 reading |
| 15 Jul 2016 | no S&P 500 reading |
| 22 Jul 2016 | no S&P 500 reading |
| 29 Jul 2016 | no S&P 500 reading |
| 5 Aug 2016 | no S&P 500 reading |
| 12 Aug 2016 | no S&P 500 reading |
| 19 Aug 2016 | no S&P 500 reading |
| 26 Aug 2016 | no S&P 500 reading |
| 2 Sep 2016 | no S&P 500 reading |
| 9 Sep 2016 | no S&P 500 reading |
| 16 Sep 2016 | no S&P 500 reading |
| 23 Sep 2016 | no S&P 500 reading |
| 30 Sep 2016 | no S&P 500 reading |
| 7 Oct 2016 | −20.4% |
| 14 Oct 2016 | −18.5% |
| 21 Oct 2016 | −19.0% |
| 28 Oct 2016 | −18.4% |
| 4 Nov 2016 | −23.4% |
| 11 Nov 2016 | −20.8% |
| 18 Nov 2016 | −25.0% |
| 25 Nov 2016 | −16.7% |
| 2 Dec 2016 | −10.6% |
| 9 Dec 2016 | −14.7% |
| 16 Dec 2016 | −15.0% |
| 23 Dec 2016 | −15.3% |
| 30 Dec 2016 | −3.3% |
| 6 Jan 2017 | +1.5% |
| 13 Jan 2017 | −5.9% |
| 20 Jan 2017 | −5.8% |
| 27 Jan 2017 | −9.2% |
| 3 Feb 2017 | +2.1% |
| 10 Feb 2017 | −3.3% |
| 17 Feb 2017 | +7.7% |
| 24 Feb 2017 | +8.1% |
| 3 Mar 2017 | +17.0% |
| 10 Mar 2017 | +13.9% |
| 17 Mar 2017 | +5.8% |
| 24 Mar 2017 | +5.6% |
| 31 Mar 2017 | −3.3% |
| 7 Apr 2017 | −0.7% |
| 13 Apr 2017 | +0.2% |
| 21 Apr 2017 | −4.1% |
| 28 Apr 2017 | −2.1% |
| 5 May 2017 | −7.9% |
| 12 May 2017 | −4.2% |
| 19 May 2017 | −11.1% |
| 26 May 2017 | −7.9% |
| 2 Jun 2017 | −15.9% |
| 9 Jun 2017 | −10.0% |
| 16 Jun 2017 | −15.0% |
| 23 Jun 2017 | −8.7% |
| 30 Jun 2017 | −3.0% |
| 7 Jul 2017 | −8.0% |
| 14 Jul 2017 | −1.5% |
| 21 Jul 2017 | +1.1% |
| 28 Jul 2017 | +0.0% |
| 4 Aug 2017 | −16.4% |
| 11 Aug 2017 | −22.8% |
| 18 Aug 2017 | −20.9% |
| 25 Aug 2017 | −24.3% |
| 1 Sep 2017 | −20.7% |
| 8 Sep 2017 | −21.2% |
| 15 Sep 2017 | −15.5% |
| 22 Sep 2017 | −22.4% |
| 29 Sep 2017 | −23.1% |
| 6 Oct 2017 | −3.3% |
| 13 Oct 2017 | −7.0% |
| 20 Oct 2017 | −5.8% |
| 27 Oct 2017 | −5.4% |
| 3 Nov 2017 | +4.0% |
| 10 Nov 2017 | +17.9% |
| 17 Nov 2017 | +16.1% |
| 24 Nov 2017 | +15.9% |
| 1 Dec 2017 | +14.0% |
| 8 Dec 2017 | +12.8% |
| 15 Dec 2017 | +19.6% |
| 22 Dec 2017 | +27.1% |
| 29 Dec 2017 | +28.7% |
| 5 Jan 2018 | +8.8% |
| 12 Jan 2018 | +14.6% |
| 19 Jan 2018 | +12.3% |
| 26 Jan 2018 | +9.3% |
| 2 Feb 2018 | +11.3% |
| 9 Feb 2018 | +1.6% |
| 16 Feb 2018 | +6.2% |
| 23 Feb 2018 | +5.4% |
| 2 Mar 2018 | +5.7% |
| 9 Mar 2018 | +4.9% |
| 16 Mar 2018 | +0.1% |
| 23 Mar 2018 | −4.0% |
| 29 Mar 2018 | −1.3% |
| 6 Apr 2018 | −6.3% |
| 13 Apr 2018 | −8.8% |
| 20 Apr 2018 | −7.9% |
| 27 Apr 2018 | −7.9% |
| 4 May 2018 | −11.1% |
| 11 May 2018 | −6.6% |
| 18 May 2018 | −5.2% |
| 25 May 2018 | −4.1% |
| 1 Jun 2018 | −6.9% |
| 8 Jun 2018 | −2.5% |
| 15 Jun 2018 | −7.6% |
| 22 Jun 2018 | −7.9% |
| 29 Jun 2018 | −15.3% |
| 6 Jul 2018 | −13.4% |
| 13 Jul 2018 | −15.4% |
| 20 Jul 2018 | −17.6% |
| 27 Jul 2018 | −13.5% |
| 3 Aug 2018 | +0.3% |
| 10 Aug 2018 | −6.9% |
| 17 Aug 2018 | −8.9% |
| 24 Aug 2018 | −7.4% |
| 31 Aug 2018 | −5.4% |
| 7 Sep 2018 | −10.9% |
| 14 Sep 2018 | −8.9% |
| 21 Sep 2018 | −4.5% |
| 28 Sep 2018 | −5.9% |
| 5 Oct 2018 | −8.2% |
| 12 Oct 2018 | −10.9% |
| 19 Oct 2018 | −8.1% |
| 26 Oct 2018 | −7.9% |
| 2 Nov 2018 | −13.5% |
| 9 Nov 2018 | +1.2% |
| 16 Nov 2018 | −4.5% |
| 23 Nov 2018 | −5.0% |
| 30 Nov 2018 | −8.4% |
| 7 Dec 2018 | −11.8% |
| 14 Dec 2018 | −12.0% |
| 21 Dec 2018 | −14.6% |
| 28 Dec 2018 | −10.7% |
| 4 Jan 2019 | −6.0% |
| 11 Jan 2019 | −1.8% |
| 18 Jan 2019 | −4.6% |
| 25 Jan 2019 | −7.4% |
| 1 Feb 2019 | −2.2% |
| 8 Feb 2019 | −14.9% |
| 15 Feb 2019 | −10.1% |
| 22 Feb 2019 | −12.7% |
| 1 Mar 2019 | −20.7% |
| 8 Mar 2019 | −17.0% |
| 15 Mar 2019 | −11.3% |
| 22 Mar 2019 | −7.6% |
| 29 Mar 2019 | −10.1% |
| 5 Apr 2019 | −18.5% |
| 12 Apr 2019 | −20.8% |
| 18 Apr 2019 | −18.1% |
| 26 Apr 2019 | −17.3% |
| 3 May 2019 | −17.8% |
| 10 May 2019 | −33.8% |
| 17 May 2019 | −41.4% |
| 24 May 2019 | −40.6% |
| 31 May 2019 | −37.0% |
| 7 Jun 2019 | −39.4% |
| 14 Jun 2019 | −42.2% |
| 21 Jun 2019 | −41.4% |
| 28 Jun 2019 | −36.5% |
| 5 Jul 2019 | −32.9% |
| 12 Jul 2019 | −32.4% |
| 19 Jul 2019 | −35.1% |
| 26 Jul 2019 | −34.7% |
| 2 Aug 2019 | −28.7% |
| 9 Aug 2019 | −13.4% |
| 16 Aug 2019 | −6.7% |
| 23 Aug 2019 | −4.1% |
| 30 Aug 2019 | +9.7% |
| 6 Sep 2019 | +14.3% |
| 13 Sep 2019 | +23.3% |
| 20 Sep 2019 | +13.2% |
| 27 Sep 2019 | +0.5% |
| 4 Oct 2019 | −1.6% |
| 11 Oct 2019 | −0.2% |
| 18 Oct 2019 | +1.0% |
| 25 Oct 2019 | +1.4% |
| 1 Nov 2019 | −5.4% |
| 8 Nov 2019 | −15.5% |
| 15 Nov 2019 | −12.4% |
| 22 Nov 2019 | −14.6% |
| 29 Nov 2019 | −11.0% |
| 6 Dec 2019 | −11.6% |
| 13 Dec 2019 | −17.1% |
| 20 Dec 2019 | −13.3% |
| 27 Dec 2019 | −7.1% |
| 3 Jan 2020 | −2.7% |
| 10 Jan 2020 | +0.4% |
| 17 Jan 2020 | +6.8% |
| 24 Jan 2020 | +7.8% |
| 31 Jan 2020 | +3.7% |
| 7 Feb 2020 | +21.8% |
| 14 Feb 2020 | +15.5% |
| 21 Feb 2020 | +14.7% |
| 28 Feb 2020 | −2.7% |
| 6 Mar 2020 | −14.6% |
| 13 Mar 2020 | −6.2% |
| 20 Mar 2020 | +5.7% |
| 27 Mar 2020 | −3.0% |
| 3 Apr 2020 | −9.0% |
| 9 Apr 2020 | −8.3% |
| 17 Apr 2020 | −12.0% |
| 24 Apr 2020 | −13.9% |
| 1 May 2020 | −12.6% |
| 8 May 2020 | −10.9% |
| 15 May 2020 | −15.6% |
| 22 May 2020 | −14.6% |
| 29 May 2020 | −3.4% |
| 5 Jun 2020 | +7.4% |
| 12 Jun 2020 | −7.0% |
| 19 Jun 2020 | −28.9% |
| 26 Jun 2020 | −11.6% |
| 2 Jul 2020 | −9.9% |
| 10 Jul 2020 | −14.0% |
| 17 Jul 2020 | −7.9% |
| 24 Jul 2020 | −12.1% |
| 31 Jul 2020 | −15.6% |
| 7 Aug 2020 | −21.3% |
| 14 Aug 2020 | −10.9% |
| 21 Aug 2020 | −12.7% |
| 28 Aug 2020 | −20.1% |
| 4 Sep 2020 | −17.8% |
| 11 Sep 2020 | −13.6% |
| 18 Sep 2020 | −9.8% |
| 25 Sep 2020 | −18.8% |
| 2 Oct 2020 | −13.4% |
| 9 Oct 2020 | −12.1% |
| 16 Oct 2020 | −14.5% |
| 23 Oct 2020 | −9.5% |
| 30 Oct 2020 | −9.8% |
| 6 Nov 2020 | −15.1% |
| 13 Nov 2020 | −10.3% |
| 20 Nov 2020 | +2.5% |
| 27 Nov 2020 | +1.3% |
| 4 Dec 2020 | +3.4% |
| 11 Dec 2020 | +3.5% |
| 18 Dec 2020 | +1.2% |
| 24 Dec 2020 | +11.0% |
| 31 Dec 2020 | +13.9% |
| 8 Jan 2021 | +7.1% |
| 15 Jan 2021 | +0.3% |
| 22 Jan 2021 | +0.4% |
| 29 Jan 2021 | +3.5% |
| 5 Feb 2021 | +11.4% |
| 12 Feb 2021 | +7.7% |
| 19 Feb 2021 | −3.5% |
| 26 Feb 2021 | −17.5% |
| 5 Mar 2021 | −24.7% |
| 12 Mar 2021 | −24.8% |
| 19 Mar 2021 | −22.2% |
| 26 Mar 2021 | −26.5% |
| 1 Apr 2021 | −33.0% |
| 9 Apr 2021 | −34.8% |
| 16 Apr 2021 | −32.5% |
| 23 Apr 2021 | −32.2% |
| 30 Apr 2021 | −34.5% |
| 7 May 2021 | −30.2% |
| 14 May 2021 | −18.4% |
| 21 May 2021 | −22.3% |
| 28 May 2021 | −7.8% |
| 4 Jun 2021 | +0.5% |
| 11 Jun 2021 | +1.9% |
| 18 Jun 2021 | −10.1% |
| 25 Jun 2021 | −6.3% |
| 2 Jul 2021 | −2.4% |
| 9 Jul 2021 | +1.0% |
| 16 Jul 2021 | −0.7% |
| 23 Jul 2021 | −1.4% |
| 30 Jul 2021 | +0.7% |
| 6 Aug 2021 | −3.6% |
| 13 Aug 2021 | −13.6% |
| 20 Aug 2021 | −10.9% |
| 27 Aug 2021 | −12.9% |
| 3 Sep 2021 | −10.5% |
| 10 Sep 2021 | −17.2% |
| 17 Sep 2021 | −11.2% |
| 24 Sep 2021 | −12.2% |
| 1 Oct 2021 | −7.7% |
| 8 Oct 2021 | −5.3% |
| 15 Oct 2021 | −5.5% |
| 22 Oct 2021 | −2.9% |
| 29 Oct 2021 | −9.8% |
| 5 Nov 2021 | −9.5% |
| 12 Nov 2021 | −10.4% |
| 19 Nov 2021 | −16.7% |
| 26 Nov 2021 | −13.2% |
| 3 Dec 2021 | −18.1% |
| 10 Dec 2021 | −13.7% |
| 17 Dec 2021 | −8.2% |
| 23 Dec 2021 | −4.1% |
| 31 Dec 2021 | −9.9% |
| 7 Jan 2022 | +1.7% |
| 14 Jan 2022 | +8.8% |
| 21 Jan 2022 | +7.6% |
| 28 Jan 2022 | +13.4% |
| 4 Feb 2022 | +14.4% |
| 11 Feb 2022 | +13.2% |
| 18 Feb 2022 | +19.9% |
| 25 Feb 2022 | +18.7% |
| 4 Mar 2022 | −11.7% |
| 11 Mar 2022 | −10.3% |
| 18 Mar 2022 | −14.9% |
| 25 Mar 2022 | −14.1% |
| 1 Apr 2022 | −15.4% |
| 8 Apr 2022 | −21.1% |
| 14 Apr 2022 | −22.2% |
| 22 Apr 2022 | −26.5% |
| 29 Apr 2022 | −22.6% |
| 6 May 2022 | −25.9% |
| 13 May 2022 | −18.2% |
| 20 May 2022 | −9.5% |
| 27 May 2022 | −10.6% |
| 3 Jun 2022 | +19.8% |
| 10 Jun 2022 | +19.0% |
| 17 Jun 2022 | +15.8% |
| 24 Jun 2022 | +11.8% |
| 1 Jul 2022 | +14.8% |
| 8 Jul 2022 | +6.9% |
| 15 Jul 2022 | +1.9% |
| 22 Jul 2022 | +0.2% |
| 29 Jul 2022 | −6.2% |
| 5 Aug 2022 | −2.7% |
| 12 Aug 2022 | −5.9% |
| 19 Aug 2022 | −18.8% |
| 26 Aug 2022 | −17.0% |
| 2 Sep 2022 | −14.8% |
| 9 Sep 2022 | −16.1% |
| 16 Sep 2022 | −16.5% |
| 23 Sep 2022 | −15.0% |
| 30 Sep 2022 | −14.1% |
| 7 Oct 2022 | −8.9% |
| 14 Oct 2022 | +4.1% |
| 21 Oct 2022 | +3.5% |
| 28 Oct 2022 | +9.5% |
| 4 Nov 2022 | +8.7% |
| 11 Nov 2022 | +9.5% |
| 18 Nov 2022 | +10.3% |
| 25 Nov 2022 | +13.5% |
| 2 Dec 2022 | +14.5% |
| 9 Dec 2022 | +12.4% |
| 16 Dec 2022 | +18.4% |
| 23 Dec 2022 | +22.6% |
| 30 Dec 2022 | +23.6% |
| 6 Jan 2023 | +31.5% |
| 13 Jan 2023 | +9.4% |
| 20 Jan 2023 | +17.9% |
| 27 Jan 2023 | +13.8% |
| 3 Feb 2023 | +16.0% |
| 10 Feb 2023 | +1.1% |
| 17 Feb 2023 | +3.4% |
| 24 Feb 2023 | +4.8% |
| 3 Mar 2023 | +0.3% |
| 10 Mar 2023 | −5.4% |
| 17 Mar 2023 | −15.7% |
| 24 Mar 2023 | −18.6% |
| 31 Mar 2023 | −20.6% |
| 6 Apr 2023 | −23.5% |
| 14 Apr 2023 | −18.0% |
| 21 Apr 2023 | −20.9% |
| 28 Apr 2023 | −24.1% |
| 5 May 2023 | −23.9% |
| 12 May 2023 | −22.5% |
| 19 May 2023 | −23.0% |
| 26 May 2023 | −26.8% |
| 2 Jun 2023 | −22.0% |
| 9 Jun 2023 | −17.6% |
| 16 Jun 2023 | −3.6% |
| 23 Jun 2023 | −4.9% |
| 30 Jun 2023 | −4.5% |
| 7 Jul 2023 | −7.8% |
| 14 Jul 2023 | −6.0% |
| 21 Jul 2023 | −1.1% |
| 28 Jul 2023 | +1.6% |
| 4 Aug 2023 | +5.8% |
| 11 Aug 2023 | +14.0% |
| 18 Aug 2023 | +16.4% |
| 25 Aug 2023 | +15.7% |
| 1 Sep 2023 | +10.2% |
| 8 Sep 2023 | +4.1% |
| 15 Sep 2023 | −5.9% |
| 22 Sep 2023 | −0.6% |
| 29 Sep 2023 | +2.4% |
| 6 Oct 2023 | +0.0% |
| 13 Oct 2023 | −4.2% |
| 20 Oct 2023 | −4.4% |
| 27 Oct 2023 | −5.6% |
| 3 Nov 2023 | −9.8% |
| 10 Nov 2023 | −17.8% |
| 17 Nov 2023 | −19.3% |
| 24 Nov 2023 | −17.5% |
| 1 Dec 2023 | −14.9% |
| 8 Dec 2023 | −6.1% |
| 15 Dec 2023 | −0.7% |
| 22 Dec 2023 | +0.4% |
| 29 Dec 2023 | −1.4% |
| 5 Jan 2024 | +15.1% |
| 12 Jan 2024 | +14.7% |
| 19 Jan 2024 | +8.0% |
| 26 Jan 2024 | +17.3% |
| 2 Feb 2024 | +14.1% |
| 9 Feb 2024 | +13.2% |
| 16 Feb 2024 | +27.4% |
| 23 Feb 2024 | +31.9% |
| 1 Mar 2024 | +22.7% |
| 8 Mar 2024 | +13.5% |
| 15 Mar 2024 | +7.6% |
| 22 Mar 2024 | +1.1% |
| 28 Mar 2024 | +0.2% |
| 5 Apr 2024 | −12.3% |
| 12 Apr 2024 | −10.2% |
| 19 Apr 2024 | −4.0% |
| 26 Apr 2024 | −7.3% |
| 3 May 2024 | −4.0% |
| 10 May 2024 | −8.4% |
| 17 May 2024 | −21.9% |
| 24 May 2024 | −27.3% |
| 31 May 2024 | −18.6% |
| 7 Jun 2024 | −19.0% |
| 14 Jun 2024 | −21.3% |
| 21 Jun 2024 | −16.0% |
| 28 Jun 2024 | −15.0% |
| 5 Jul 2024 | −19.5% |
| 12 Jul 2024 | −10.4% |
| 19 Jul 2024 | −5.6% |
| 26 Jul 2024 | −2.7% |
| 2 Aug 2024 | −3.5% |
| 9 Aug 2024 | +3.2% |
| 16 Aug 2024 | +1.5% |
| 23 Aug 2024 | +6.8% |
| 30 Aug 2024 | +7.1% |
| 6 Sep 2024 | +6.5% |
| 13 Sep 2024 | +11.1% |
| 20 Sep 2024 | +4.4% |
| 27 Sep 2024 | +3.6% |
| 4 Oct 2024 | +9.0% |
| 11 Oct 2024 | −2.3% |
| 18 Oct 2024 | −7.2% |
| 25 Oct 2024 | −11.7% |
| 1 Nov 2024 | −9.3% |
| 8 Nov 2024 | −2.2% |
| 15 Nov 2024 | +4.4% |
| 22 Nov 2024 | +7.8% |
| 29 Nov 2024 | +1.5% |
| 6 Dec 2024 | +0.4% |
| 13 Dec 2024 | +0.8% |
| 20 Dec 2024 | +5.9% |
| 27 Dec 2024 | +3.9% |
| 3 Jan 2025 | +2.6% |
| 10 Jan 2025 | +2.4% |
| 17 Jan 2025 | −6.1% |
| 24 Jan 2025 | −7.1% |
| 31 Jan 2025 | −8.3% |
| 7 Feb 2025 | −17.6% |
| 14 Feb 2025 | −19.9% |
| 21 Feb 2025 | −16.6% |
| 28 Feb 2025 | −28.1% |
| 7 Mar 2025 | −18.9% |
| 14 Mar 2025 | −21.1% |
| 21 Mar 2025 | −22.3% |
| 28 Mar 2025 | −23.8% |
| 4 Apr 2025 | −23.3% |
| 11 Apr 2025 | −27.4% |
| 17 Apr 2025 | −21.2% |
| 25 Apr 2025 | −18.0% |
| 2 May 2025 | −17.5% |
| 9 May 2025 | −12.2% |
| 16 May 2025 | −15.6% |
| 23 May 2025 | −22.8% |
| 30 May 2025 | −4.0% |
| 6 Jun 2025 | −13.8% |
| 13 Jun 2025 | −8.1% |
| 20 Jun 2025 | −8.4% |
| 27 Jun 2025 | −6.9% |
| 3 Jul 2025 | −1.5% |
| 11 Jul 2025 | +4.2% |
| 18 Jul 2025 | −1.8% |
| 25 Jul 2025 | +0.0% |
| 1 Aug 2025 | −7.8% |
| 8 Aug 2025 | −2.3% |
| 15 Aug 2025 | +11.7% |
| 22 Aug 2025 | +17.0% |
| 29 Aug 2025 | +10.6% |
| 5 Sep 2025 | +12.5% |
| 12 Sep 2025 | +1.5% |
| 19 Sep 2025 | −0.1% |
| 26 Sep 2025 | −2.0% |
| 3 Oct 2025 | +2.3% |
| 10 Oct 2025 | +2.1% |
| 17 Oct 2025 | +8.7% |
| 24 Oct 2025 | +3.7% |
| 31 Oct 2025 | +7.9% |
| 7 Nov 2025 | −1.0% |
| 14 Nov 2025 | −3.4% |
| 21 Nov 2025 | −3.9% |
| 28 Nov 2025 | −4.6% |
| 5 Dec 2025 | −1.8% |
| 12 Dec 2025 | +13.3% |
| 19 Dec 2025 | +18.0% |
| 26 Dec 2025 | +25.1% |
| 2 Jan 2026 | +20.2% |
| 9 Jan 2026 | +24.7% |
| 16 Jan 2026 | +22.3% |
| 23 Jan 2026 | +25.9% |
| 30 Jan 2026 | +24.9% |
| 6 Feb 2026 | +41.1% |
| 13 Feb 2026 | +45.6% |
| 20 Feb 2026 | +47.6% |
| 27 Feb 2026 | +39.3% |
| 6 Mar 2026 | +31.5% |
| 13 Mar 2026 | +18.8% |
| 20 Mar 2026 | +15.4% |
| 27 Mar 2026 | +14.1% |
| 2 Apr 2026 | +11.9% |
| 10 Apr 2026 | +7.7% |
| 17 Apr 2026 | +11.5% |
| 24 Apr 2026 | +6.9% |
| 1 May 2026 | +10.8% |
| 8 May 2026 | +11.0% |
| 15 May 2026 | −3.9% |
| 22 May 2026 | −3.6% |
| 29 May 2026 | −1.4% |
| 5 Jun 2026 | +2.5% |
| 12 Jun 2026 | +10.0% |
| 18 Jun 2026 | +1.3% |
| 26 Jun 2026 | +10.2% |
| 2 Jul 2026 | +10.7% |
| 10 Jul 2026 | +9.7% |
| 17 Jul 2026 | +13.1% |
| 24 Jul 2026 | +14.7% |
| 31 Jul 2026 | +13.1% |
| 7 Aug 2026 | −9.1% |
| 14 Aug 2026 | −6.5% |
| 21 Aug 2026 | −4.7% |
| 28 Aug 2026 | −1.2% |
| 4 Sep 2026 | +1.9% |
| 11 Sep 2026 | −2.9% |
| 18 Sep 2026 | +8.3% |
| 25 Sep 2026 | +3.4% |
| 2 Oct 2026 | +2.1% |
| 9 Oct 2026 | +5.3% |
| 16 Oct 2026 | +5.2% |
| 23 Oct 2026 | +1.6% |
| 30 Oct 2026 | +7.3% |
| 4 Nov 2026 | +17.8% |
Over the last 10 years the share price moved −57% while the S&P 500 moved +261%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week.
This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.
What dividend does Viatris pay?
Viatris Inc. paid $0.48 per share over the last four reported quarters. The most recent declaration was $0.12 for Jun 2026. At today's price of $19.22 that is a yield of 2.50%, based on dividends already paid, not a forecast.
A dividend is cash paid out for each share. The 12-month total is the four most recent quarters added together.
Dividend per share each quarter: latest $0.12 (Jun 2026)
- Dividend per share $0.12
| Quarter | Dividend per share |
|---|---|
| Sep 2023 | $0.12 |
| Dec 2023 | $0.12 |
| Mar 2024 | $0.12 |
| Jun 2024 | $0.12 |
| Sep 2024 | $0.12 |
| Dec 2024 | $0.12 |
| Mar 2025 | $0.12 |
| Jun 2025 | $0.12 |
| Sep 2025 | $0.12 |
| Dec 2025 | $0.12 |
| Mar 2026 | $0.12 |
| Jun 2026 | $0.12 |
Which stock lists is Viatris on?
Viatris is on one of our US lists: S&P 500 companies.
Is Viatris profitable?
Viatris Inc. posted a net loss of $119 M in the Jun 2026 quarter. The full FY25 year was a loss of $3.5 B. That loss is 3.2% of the quarter's revenue. The same quarter a year earlier lost $4.6 M. 8 of the last 12 reported quarters were loss-making.
Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.
FY25 profit −$3.5 B
- Net profit −$3.5 B
| Quarter | Net profit |
|---|---|
| FY21 | −$1.3 B |
| FY22 | $2.1 B |
| FY23 | $54.7 M |
| FY24 | −$634 M |
| FY25 | −$3.5 B |
Growth on a year earlier
- Growth on a year earlier −1,259.4%
| Quarter | Growth on a year earlier |
|---|---|
| FY21 | – |
| FY22 | – |
| FY23 | −97.4% |
| FY24 | −1,259.4% |
| FY25 | – |
Jun 2026: −$119 M
- Net profit (quarterly) −$119 M
| Quarter | Net profit (quarterly) |
|---|---|
| Sep 2023 | $332 M |
| Dec 2023 | −$766 M |
| Mar 2024 | $114 M |
| Jun 2024 | −$326 M |
| Sep 2024 | $94.8 M |
| Dec 2024 | −$517 M |
| Mar 2025 | −$3.0 B |
| Jun 2025 | −$4.6 M |
| Sep 2025 | −$128 M |
| Dec 2025 | −$340 M |
| Mar 2026 | $176 M |
| Jun 2026 | −$119 M |
Growth on a year earlier
- Growth on a year earlier −235.2%
| Quarter | Growth on a year earlier |
|---|---|
| Sep 2023 | −6.4% |
| Dec 2023 | −175.7% |
| Mar 2024 | −49.3% |
| Jun 2024 | −223.6% |
| Sep 2024 | −71.4% |
| Dec 2024 | – |
| Mar 2025 | −2,770.8% |
| Jun 2025 | – |
| Sep 2025 | −235.2% |
| Dec 2025 | – |
| Mar 2026 | – |
| Jun 2026 | – |
How much revenue does Viatris make, and is it growing?
Viatris Inc. reported $3.8 B of revenue in the Jun 2026 quarter, +4.9% on the same quarter a year earlier. That is the 4th quarter in a row with growth on the year before. Over 4 years it has grown −5.4% a year on average. The last full year, FY25, came in at $14.3 B.
Revenue is everything the company billed its customers in the period.
The last four reported quarters add to $14.7 B.
FY25 revenue was $14.3 B, −3.0% on the year before.
FY25 revenue $14.3 B (−3.0% on the year before), −5.4% a year over 4 years
- Revenue $14.3 B
| Quarter | Revenue |
|---|---|
| FY21 | $17.9 B |
| FY22 | $16.3 B |
| FY23 | $15.4 B |
| FY24 | $14.7 B |
| FY25 | $14.3 B |
Growth on a year earlier
- Growth on a year earlier −3%
| Quarter | Growth on a year earlier |
|---|---|
| FY21 | – |
| FY22 | −9.1% |
| FY23 | −5.1% |
| FY24 | −4.5% |
| FY25 | −3% |
Jun 2026: $3.8 B (+4.9% on a year earlier), the 4th quarter in a row of growth
- Revenue (quarterly) $3.8 B
| Quarter | Revenue (quarterly) |
|---|---|
| Sep 2023 | $3.9 B |
| Dec 2023 | $3.8 B |
| Mar 2024 | $3.7 B |
| Jun 2024 | $3.8 B |
| Sep 2024 | $3.8 B |
| Dec 2024 | $3.5 B |
| Mar 2025 | $3.3 B |
| Jun 2025 | $3.6 B |
| Sep 2025 | $3.8 B |
| Dec 2025 | $3.7 B |
| Mar 2026 | $3.5 B |
| Jun 2026 | $3.8 B |
Growth on a year earlier
- Growth on a year earlier 4.9%
| Quarter | Growth on a year earlier |
|---|---|
| Sep 2023 | −3.3% |
| Dec 2023 | −1% |
| Mar 2024 | −1.8% |
| Jun 2024 | −3.1% |
| Sep 2024 | −4.8% |
| Dec 2024 | −8.1% |
| Mar 2025 | −11.2% |
| Jun 2025 | −5.6% |
| Sep 2025 | 0.2% |
| Dec 2025 | 5% |
| Mar 2026 | 8.1% |
| Jun 2026 | 4.9% |
Recent pace: the last four quarters grew +4.6% on average, against −5.4% a year over the longer run, so this year is growing faster than its own long-run rate.
Is growth speeding up? Revenue over the last 12 months grew +4.4%, against −1.7% a year over the last 8 quarters (accelerating).
How much of every $100 of sales does Viatris keep?
Viatris Inc.'s operating margin was 12.6% in the Jun 2026 quarter, 3.1 percentage points higher than the same quarter a year ago. Across 5 years it has been between 6.1% and 16.9%. The latest quarter is within that range.
Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.
Why the margin moved: operating margin changed +3.1 percentage points on the year while gross margin changed +1.9 points. So the gain came mostly from the gross margin, which means input costs and prices charged.
FY25: 8.6%, within a range of 6.1% to 16.9% over 5 years
- Operating margin 8.6%
| Quarter | Operating margin |
|---|---|
| FY21 | 6.1% |
| FY22 | 16.9% |
| FY23 | 13.2% |
| FY24 | 10.9% |
| FY25 | 8.6% |
Change on the year before (points)
- Change on the year before (points) −2.3 pts
| Quarter | Change on the year before (points) |
|---|---|
| FY21 | – |
| FY22 | +10.8 pts |
| FY23 | −3.7 pts |
| FY24 | −2.3 pts |
| FY25 | −2.3 pts |
Jun 2026: operating margin 12.6% (+3.1 points on a year earlier)
- Operating margin 12.6%
| Quarter | Operating margin |
|---|---|
| Sep 2023 | 14.5% |
| Dec 2023 | 13.3% |
| Mar 2024 | 11.6% |
| Jun 2024 | 9.3% |
| Sep 2024 | 13.3% |
| Dec 2024 | 9.2% |
| Mar 2025 | 2.6% |
| Jun 2025 | 9.5% |
| Sep 2025 | 10.8% |
| Dec 2025 | 7.8% |
| Mar 2026 | 6.8% |
| Jun 2026 | 12.6% |
Change on a year earlier (points)
- Change on a year earlier (points) +3.1 pts
| Quarter | Change on a year earlier (points) |
|---|---|
| Sep 2023 | −4.0 pts |
| Dec 2023 | +0.6 pts |
| Mar 2024 | −2.5 pts |
| Jun 2024 | −4.7 pts |
| Sep 2024 | −1.2 pts |
| Dec 2024 | −4.1 pts |
| Mar 2025 | −9.0 pts |
| Jun 2025 | +0.2 pts |
| Sep 2025 | −2.5 pts |
| Dec 2025 | −1.4 pts |
| Mar 2026 | +4.2 pts |
| Jun 2026 | +3.1 pts |
Is Viatris' profit turning into cash?
Over the last 2 years, 277% of Viatris Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $2.3 B of operating cash against −$3.5 B of profit. After $379 M of spending on assets, $1.9 B was left over as free cash.
The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.
Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.
FY25: operating cash $2.3 B against profit −$3.5 B; 277% of 2 years' profit came in as cash
- Operating cash $2.3 B
- Net profit −$3.5 B
- Free cash $1.9 B
| Quarter | Operating cash | Net profit | Free cash |
|---|---|---|---|
| FY21 | $3.0 B | −$1.3 B | $2.6 B |
| FY22 | $3.0 B | $2.1 B | $2.6 B |
| FY23 | $2.9 B | $54.7 M | $2.5 B |
| FY24 | $2.3 B | −$634 M | $2.0 B |
| FY25 | $2.3 B | −$3.5 B | $1.9 B |
Jun 2026: operating cash $382 M
- Operating cash (quarterly) $382 M
| Quarter | Operating cash (quarterly) |
|---|---|
| Sep 2023 | $835 M |
| Dec 2023 | $569 M |
| Mar 2024 | $615 M |
| Jun 2024 | $379 M |
| Sep 2024 | $827 M |
| Dec 2024 | $483 M |
| Mar 2025 | $536 M |
| Jun 2025 | $220 M |
| Sep 2025 | $745 M |
| Dec 2025 | $816 M |
| Mar 2026 | $388 M |
| Jun 2026 | $382 M |
Operating cash as % of profit
- Operating cash as % of profit 220%
| Quarter | Operating cash as % of profit |
|---|---|
| Sep 2023 | 252% |
| Dec 2023 | – |
| Mar 2024 | 540% |
| Jun 2024 | – |
| Sep 2024 | 872% |
| Dec 2024 | – |
| Mar 2025 | – |
| Jun 2025 | – |
| Sep 2025 | – |
| Dec 2025 | – |
| Mar 2026 | 220% |
| Jun 2026 | – |
Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.
What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building.
Where does Viatris' cash go?
Viatris Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $1.1 B on assets over the last 3 years. Averaged over those years that is 2.5% of FY25 revenue a year.
Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.
Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.
Spending on assets: $1.1 B over the last 3 years.
FY25: capex $379 M, steady spending
- Capex $379 M
| Quarter | Capex |
|---|---|
| FY21 | $457 M |
| FY22 | $406 M |
| FY23 | $377 M |
| FY24 | $326 M |
| FY25 | $379 M |
Jun 2026: capex $52.8 M in the quarter
- Capex (quarterly) $52.8 M
| Quarter | Capex (quarterly) |
|---|---|
| Sep 2023 | $95.9 M |
| Dec 2023 | $166 M |
| Mar 2024 | $49.8 M |
| Jun 2024 | $58.8 M |
| Sep 2024 | $77.0 M |
| Dec 2024 | $140 M |
| Mar 2025 | $42.6 M |
| Jun 2025 | $52.9 M |
| Sep 2025 | $86.8 M |
| Dec 2025 | $197 M |
| Mar 2026 | $39.9 M |
| Jun 2026 | $52.8 M |
Free cash
- Free cash $329 M
| Quarter | Free cash |
|---|---|
| Sep 2023 | $739 M |
| Dec 2023 | $403 M |
| Mar 2024 | $565 M |
| Jun 2024 | $320 M |
| Sep 2024 | $750 M |
| Dec 2024 | $342 M |
| Mar 2025 | $493 M |
| Jun 2025 | $167 M |
| Sep 2025 | $658 M |
| Dec 2025 | $619 M |
| Mar 2026 | $348 M |
| Jun 2026 | $329 M |
In short: most of the cash goes on covering the loss, not on new assets; spending on assets is small next to it.
What is Viatris' P/E ratio, and how does it compare with its own history?
Viatris Inc.'s P/E is 304.4×, near the high end of its own history: higher than 93% of past readings. Its usual P/E (the middle reading) is 15.3×, over 2.3 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.
P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.
P/E 304.4× against a usual 15.3×: near the high end of its own history: higher than 93% of past readings
- P/E 45.8×
- Median 15.3×
| Week | P/E | Median |
|---|---|---|
| 1 Apr 2022 | 45.8× | 15.3× |
| 8 Apr 2022 | 45.8× | 15.3× |
| 14 Apr 2022 | 45.8× | 15.3× |
| 22 Apr 2022 | 45.8× | 15.3× |
| 29 Apr 2022 | 45.8× | 15.3× |
| 6 May 2022 | 45.8× | 15.3× |
| 13 May 2022 | 45.8× | 15.3× |
| 20 May 2022 | 45.8× | 15.3× |
| 27 May 2022 | 45.8× | 15.3× |
| 3 Jun 2022 | 45.8× | 15.3× |
| 10 Jun 2022 | 45.8× | 15.3× |
| 17 Jun 2022 | 45.8× | 15.3× |
| 24 Jun 2022 | 45.8× | 15.3× |
| 1 Jul 2022 | 17.1× | 15.3× |
| 8 Jul 2022 | 16.5× | 15.3× |
| 15 Jul 2022 | 15.7× | 15.3× |
| 22 Jul 2022 | 15.3× | 15.3× |
| 29 Jul 2022 | 15.5× | 15.3× |
| 5 Aug 2022 | 15.5× | 15.3× |
| 12 Aug 2022 | 17.8× | 15.3× |
| 19 Aug 2022 | 16.9× | 15.3× |
| 26 Aug 2022 | 15.8× | 15.3× |
| 2 Sep 2022 | 15.1× | 15.3× |
| 9 Sep 2022 | 15.8× | 15.3× |
| 16 Sep 2022 | 14.9× | 15.3× |
| 23 Sep 2022 | 13.9× | 15.3× |
| 30 Sep 2022 | 12.9× | 15.3× |
| 7 Oct 2022 | 13.3× | 15.3× |
| 14 Oct 2022 | 14.5× | 15.3× |
| 21 Oct 2022 | 14.2× | 15.3× |
| 28 Oct 2022 | 15.3× | 15.3× |
| 4 Nov 2022 | 14.7× | 15.3× |
| 11 Nov 2022 | 17.4× | 15.3× |
| 18 Nov 2022 | 16.7× | 15.3× |
| 25 Nov 2022 | 16.9× | 15.3× |
| 2 Dec 2022 | 16.9× | 15.3× |
| 9 Dec 2022 | 16.4× | 15.3× |
| 16 Dec 2022 | 16.6× | 15.3× |
| 23 Dec 2022 | 16.7× | 15.3× |
| 30 Dec 2022 | 16.9× | 15.3× |
| 6 Jan 2023 | 7.09× | 15.3× |
| 13 Jan 2023 | 6.76× | 15.3× |
| 20 Jan 2023 | 6.80× | 15.3× |
| 27 Jan 2023 | 6.97× | 15.3× |
| 3 Feb 2023 | 7.14× | 15.3× |
| 10 Feb 2023 | 6.94× | 15.3× |
| 17 Feb 2023 | 6.85× | 15.3× |
| 24 Feb 2023 | 6.74× | 15.3× |
| 3 Mar 2023 | 6.52× | 15.3× |
| 10 Mar 2023 | 5.86× | 15.3× |
| 17 Mar 2023 | 5.52× | 15.3× |
| 24 Mar 2023 | 5.47× | 15.3× |
| 31 Mar 2023 | 6.15× | 15.3× |
| 6 Apr 2023 | 6.34× | 15.3× |
| 14 Apr 2023 | 6.31× | 15.3× |
| 21 Apr 2023 | 6.17× | 15.3× |
| 28 Apr 2023 | 5.97× | 15.3× |
| 5 May 2023 | 5.93× | 15.3× |
| 12 May 2023 | 5.93× | 15.3× |
| 19 May 2023 | 5.97× | 15.3× |
| 26 May 2023 | 5.82× | 15.3× |
| 2 Jun 2023 | 5.97× | 15.3× |
| 9 Jun 2023 | 6.00× | 15.3× |
| 16 Jun 2023 | 6.58× | 15.3× |
| 23 Jun 2023 | 6.24× | 15.3× |
| 30 Jun 2023 | 6.54× | 15.3× |
| 7 Jul 2023 | 6.47× | 15.3× |
| 14 Jul 2023 | 6.66× | 15.3× |
| 21 Jul 2023 | 6.87× | 15.3× |
| 28 Jul 2023 | 6.82× | 15.3× |
| 4 Aug 2023 | 6.94× | 15.3× |
| 11 Aug 2023 | 7.44× | 15.3× |
| 18 Aug 2023 | 7.38× | 15.3× |
| 25 Aug 2023 | 7.19× | 15.3× |
| 1 Sep 2023 | 7.08× | 15.3× |
| 8 Sep 2023 | 6.63× | 15.3× |
| 15 Sep 2023 | 6.41× | 15.3× |
| 22 Sep 2023 | 6.32× | 15.3× |
| 29 Sep 2023 | 6.47× | 15.3× |
| 6 Oct 2023 | 6.42× | 15.3× |
| 13 Oct 2023 | 6.20× | 15.3× |
| 20 Oct 2023 | 6.18× | 15.3× |
| 27 Oct 2023 | 5.83× | 15.3× |
| 3 Nov 2023 | 6.16× | 15.3× |
| 10 Nov 2023 | 6.11× | 15.3× |
| 17 Nov 2023 | 6.28× | 15.3× |
| 24 Nov 2023 | 6.27× | 15.3× |
| 1 Dec 2023 | 6.23× | 15.3× |
| 8 Dec 2023 | 6.53× | 15.3× |
| 15 Dec 2023 | 6.82× | 15.3× |
| 22 Dec 2023 | 7.08× | 15.3× |
| 29 Dec 2023 | 7.20× | 15.3× |
| 5 Jan 2024 | 45.8× | 15.3× |
| 12 Jan 2024 | 45.8× | 15.3× |
| 19 Jan 2024 | 45.8× | 15.3× |
| 26 Jan 2024 | 45.8× | 15.3× |
| 2 Feb 2024 | 45.8× | 15.3× |
| 9 Feb 2024 | 45.8× | 15.3× |
| 16 Feb 2024 | 45.8× | 15.3× |
| 23 Feb 2024 | 45.8× | 15.3× |
| 1 Mar 2024 | 45.8× | 15.3× |
| 8 Mar 2024 | 45.8× | 15.3× |
| 15 Mar 2024 | 45.8× | 15.3× |
| 22 Mar 2024 | 45.8× | 15.3× |
| 28 Mar 2024 | 45.8× | 15.3× |
| 5 Apr 2024 | 45.8× | 15.3× |
| 12 Apr 2024 | 45.8× | 15.3× |
| 19 Apr 2024 | 45.8× | 15.3× |
| 26 Apr 2024 | 45.8× | 15.3× |
| 3 May 2024 | 45.8× | 15.3× |
| 10 May 2024 | 45.8× | 15.3× |
| 17 May 2024 | 45.8× | 15.3× |
| 24 May 2024 | 45.8× | 15.3× |
| 31 May 2024 | 45.8× | 15.3× |
| 7 Jun 2024 | 45.8× | 15.3× |
| 14 Jun 2024 | 45.8× | 15.3× |
| 21 Jun 2024 | 45.8× | 15.3× |
| 28 Jun 2024 | 45.8× | 15.3× |
| 5 Jul 2024 | 45.8× | 15.3× |
| 12 Jul 2024 | 45.8× | 15.3× |
| 19 Jul 2024 | 45.8× | 15.3× |
| 26 Jul 2024 | 45.8× | 15.3× |
| 2 Aug 2024 | 45.8× | 15.3× |
Earnings per share, 12 months
- Earnings per share, 12 months $0.04
| Week | Earnings per share, 12 months |
|---|---|
| 1 Apr 2022 | – |
| 8 Apr 2022 | – |
| 14 Apr 2022 | – |
| 22 Apr 2022 | – |
| 29 Apr 2022 | – |
| 6 May 2022 | – |
| 13 May 2022 | – |
| 20 May 2022 | – |
| 27 May 2022 | – |
| 3 Jun 2022 | – |
| 10 Jun 2022 | – |
| 17 Jun 2022 | – |
| 24 Jun 2022 | $0.14 |
| 1 Jul 2022 | $0.14 |
| 8 Jul 2022 | $0.14 |
| 15 Jul 2022 | $0.14 |
| 22 Jul 2022 | $0.14 |
| 29 Jul 2022 | $0.14 |
| 5 Aug 2022 | $0.14 |
| 12 Aug 2022 | $0.14 |
| 19 Aug 2022 | $0.14 |
| 26 Aug 2022 | $0.14 |
| 2 Sep 2022 | $0.14 |
| 9 Sep 2022 | $0.14 |
| 16 Sep 2022 | $0.14 |
| 23 Sep 2022 | $0.14 |
| 30 Sep 2022 | $0.66 |
| 7 Oct 2022 | $0.66 |
| 14 Oct 2022 | $0.66 |
| 21 Oct 2022 | $0.66 |
| 28 Oct 2022 | $0.66 |
| 4 Nov 2022 | $0.66 |
| 11 Nov 2022 | $0.66 |
| 18 Nov 2022 | $0.66 |
| 25 Nov 2022 | $0.66 |
| 2 Dec 2022 | $0.66 |
| 9 Dec 2022 | $0.66 |
| 16 Dec 2022 | $0.66 |
| 23 Dec 2022 | $0.66 |
| 30 Dec 2022 | $0.66 |
| 6 Jan 2023 | $0.66 |
| 13 Jan 2023 | $0.66 |
| 20 Jan 2023 | $0.66 |
| 27 Jan 2023 | $0.66 |
| 3 Feb 2023 | $0.66 |
| 10 Feb 2023 | $0.66 |
| 17 Feb 2023 | $0.66 |
| 24 Feb 2023 | $0.66 |
| 3 Mar 2023 | $0.66 |
| 10 Mar 2023 | $0.66 |
| 17 Mar 2023 | $0.66 |
| 24 Mar 2023 | $0.66 |
| 31 Mar 2023 | $1.56 |
| 6 Apr 2023 | $1.56 |
| 14 Apr 2023 | $1.56 |
| 21 Apr 2023 | $1.56 |
| 28 Apr 2023 | $1.56 |
| 5 May 2023 | $1.56 |
| 12 May 2023 | $1.56 |
| 19 May 2023 | $1.56 |
| 26 May 2023 | $1.56 |
| 2 Jun 2023 | $1.56 |
| 9 Jun 2023 | $1.56 |
| 16 Jun 2023 | $1.56 |
| 23 Jun 2023 | $1.56 |
| 30 Jun 2023 | $1.52 |
| 7 Jul 2023 | $1.52 |
| 14 Jul 2023 | $1.52 |
| 21 Jul 2023 | $1.52 |
| 28 Jul 2023 | $1.52 |
| 4 Aug 2023 | $1.52 |
| 11 Aug 2023 | $1.52 |
| 18 Aug 2023 | $1.52 |
| 25 Aug 2023 | $1.52 |
| 1 Sep 2023 | $1.52 |
| 8 Sep 2023 | $1.52 |
| 15 Sep 2023 | $1.52 |
| 22 Sep 2023 | $1.52 |
| 29 Sep 2023 | $1.52 |
| 6 Oct 2023 | $1.52 |
| 13 Oct 2023 | $1.52 |
| 20 Oct 2023 | $1.52 |
| 27 Oct 2023 | $1.52 |
| 3 Nov 2023 | $1.52 |
| 10 Nov 2023 | $1.52 |
| 17 Nov 2023 | $1.52 |
| 24 Nov 2023 | $1.52 |
| 1 Dec 2023 | $1.52 |
| 8 Dec 2023 | $1.52 |
| 15 Dec 2023 | $1.52 |
| 22 Dec 2023 | $1.52 |
| 29 Dec 2023 | $1.50 |
| 5 Jan 2024 | $1.50 |
| 12 Jan 2024 | $1.50 |
| 19 Jan 2024 | $1.50 |
| 26 Jan 2024 | $1.50 |
| 2 Feb 2024 | $1.50 |
| 9 Feb 2024 | $1.50 |
| 16 Feb 2024 | $1.50 |
| 23 Feb 2024 | $1.50 |
| 1 Mar 2024 | $1.50 |
| 8 Mar 2024 | $1.50 |
| 15 Mar 2024 | $1.50 |
| 22 Mar 2024 | $1.50 |
| 28 Mar 2024 | $0.04 |
| 5 Apr 2024 | $0.04 |
| 12 Apr 2024 | $0.04 |
| 19 Apr 2024 | $0.04 |
| 26 Apr 2024 | $0.04 |
| 3 May 2024 | $0.04 |
| 10 May 2024 | $0.04 |
| 17 May 2024 | $0.04 |
| 24 May 2024 | $0.04 |
| 31 May 2024 | $0.04 |
| 7 Jun 2024 | $0.04 |
| 14 Jun 2024 | $0.04 |
| 21 Jun 2024 | $0.04 |
| 28 Jun 2024 | $0.04 |
| 5 Jul 2024 | $0.04 |
| 12 Jul 2024 | $0.04 |
| 19 Jul 2024 | $0.04 |
| 26 Jul 2024 | $0.04 |
| 2 Aug 2024 | $0.04 |
PEG 1.53 at the Jun 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate
- PEG 1.53×
- PEG = 1.0 1.00×
| Quarter | PEG | PEG = 1.0 |
|---|---|---|
| Sep 2021 | 1.02× | 1.00× |
| Dec 2021 | 0.56× | 1.00× |
| Mar 2022 | 0.56× | 1.00× |
| Jun 2022 | 5.43× | 1.00× |
| Sep 2022 | 1.50× | 1.00× |
| Dec 2022 | 2.77× | 1.00× |
| Mar 2023 | 0.53× | 1.00× |
| Jun 2023 | 0.53× | 1.00× |
| Sep 2023 | 0.53× | 1.00× |
| Dec 2023 | 0.53× | 1.00× |
| Mar 2024 | 0.53× | 1.00× |
| Jun 2024 | 0.53× | 1.00× |
| Sep 2024 | 0.53× | 1.00× |
| Dec 2024 | 0.53× | 1.00× |
| Mar 2025 | 0.53× | 1.00× |
| Jun 2025 | 0.53× | 1.00× |
| Sep 2025 | 0.53× | 1.00× |
| Dec 2025 | 0.53× | 1.00× |
| Mar 2026 | 1.51× | 1.00× |
| Jun 2026 | 1.53× | 1.00× |
In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple.
Is the Viatris business getting better or worse?
Viatris Inc.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps.
Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.
Growth year by year: revenue −3.0% in FY25
- Revenue growth −3.0%
| Quarter | Revenue growth |
|---|---|
| FY21 | – |
| FY22 | −9.1% |
| FY23 | −5.1% |
| FY24 | −4.5% |
| FY25 | −3% |
Profit growth, EPS growth
- Profit growth −300%
- EPS growth −300%
| Quarter | Profit growth | EPS growth |
|---|---|---|
| FY21 | – | – |
| FY22 | – | – |
| FY23 | −97.4% | −97.3% |
| FY24 | −300% | −300% |
| FY25 | – | – |
Three growth lines over twelve quarters: revenue accelerating
- Revenue 4.4%
| Quarter | Revenue |
|---|---|
| Sep 2023 | −7.5% |
| Dec 2023 | −5.1% |
| Mar 2024 | −2.8% |
| Jun 2024 | −2.3% |
| Sep 2024 | −2.7% |
| Dec 2024 | −4.5% |
| Mar 2025 | −6.7% |
| Jun 2025 | −7.4% |
| Sep 2025 | −6.1% |
| Dec 2025 | −3% |
| Mar 2026 | 1.6% |
| Jun 2026 | 4.4% |
Profit, EPS
- Profit −235.2%
- EPS −300%
| Quarter | Profit | EPS |
|---|---|---|
| Sep 2023 | −6.4% | 128.5% |
| Dec 2023 | −175.7% | −97.7% |
| Mar 2024 | −49.3% | −103.7% |
| Jun 2024 | −223.6% | −136.2% |
| Sep 2024 | −71.4% | −149.3% |
| Dec 2024 | – | −300% |
| Mar 2025 | −300% | – |
| Jun 2025 | – | – |
| Sep 2025 | −235.2% | – |
| Dec 2025 | – | – |
| Mar 2026 | – | – |
| Jun 2026 | – | – |
ROCE: the return line, worked out each quarter
- ROCE 4.7%
| Quarter | ROCE |
|---|---|
| Sep 2023 | – |
| Dec 2023 | 5.2% |
| Mar 2024 | 5% |
| Jun 2024 | 4.7% |
| Sep 2024 | 4.5% |
| Dec 2024 | 4.2% |
| Mar 2025 | – |
| Jun 2025 | – |
| Sep 2025 | – |
| Dec 2025 | – |
| Mar 2026 | 4.1% |
| Jun 2026 | 4.7% |
Why it matters: with too little history, we say so rather than guess a direction.
One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result.
There are fewer than eight usable quarters, so this page does not guess a direction from so little history.
Compound annual growth rate (%)
Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.
| Measure | 1yr | 3yr | 5yr | 10yr |
|---|---|---|---|---|
| Revenue | −3.0% | −4.2% | — | — |
| Stock price | +89.9% | +27.5% | +7.0% | −5.8% |
How much does Viatris earn on its capital?
Viatris Inc. earned a ROE of −24% in FY25. Its return on capital used (ROIC) is 0.7 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −24.6% net margin and 0.38× asset turnover (sales divided by assets).
Return on equity (ROE) is the profit the business earns on its shareholders’ money. We do not have the full capital split, so ROE is the longest history we can draw here.
Why the return is what it is (FY25): a −24.6% net margin × 0.38× asset turnover × 2.53× leverage (assets divided by equity) ≈ −23.7% on equity. The margin does its share; borrowing is a big part of it.
The key test, return on capital used minus the cost of capital: 5.9% − 6.6% = −0.7 percentage points. The 6.6% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.
The 5.9% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 4.1%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method.
FY25: ROE −24%, the full history
- ROE −23.9%
- ROIC (annual) 4.1%
- Cost of capital 6.6%
| Quarter | ROE | ROIC (annual) | Cost of capital |
|---|---|---|---|
| FY21 | −6.2% | 2.4% | 6.6% |
| FY22 | 9.9% | 4.9% | 6.6% |
| FY23 | 0.3% | 1.4% | 6.6% |
| FY24 | −3.4% | 4.6% | 6.6% |
| FY25 | −23.9% | 4.1% | 6.6% |
Jun 2026: ROIC 4.5% (last 12 months) against a 6.6% cost of capital
- ROIC (12 months) 4.5%
- ROE (12 months) −7.7%
- Cost of capital 6.6%
| Quarter | ROIC (12 months) | ROE (12 months) | Cost of capital |
|---|---|---|---|
| Sep 2023 | 4.5% | 36.8% | 6.6% |
| Dec 2023 | 4.1% | 35.9% | 6.6% |
| Mar 2024 | 4.6% | 1% | 6.6% |
| Jun 2024 | 4.3% | −1% | 6.6% |
| Sep 2024 | 4.2% | −12.7% | 6.6% |
| Dec 2024 | 4.4% | −17.2% | 6.6% |
| Mar 2025 | 4% | −13.2% | 6.6% |
| Jun 2025 | 3.7% | −86.5% | 6.6% |
| Sep 2025 | 3.9% | −80% | 6.6% |
| Dec 2025 | 3.9% | −85.2% | 6.6% |
| Mar 2026 | 3.9% | −83.5% | 6.6% |
| Jun 2026 | 4.5% | −7.7% | 6.6% |
Does Viatris have too much debt?
Viatris Inc. has total debt of $13.6 B against shareholder equity of $14.3 B as of Jun 2026, so its debt is 0.96× its equity. Year by year, that ratio went from 1.14 in FY21 to 1.00 in FY25. Keep that borrowing in mind when reading the returns on this page.
Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.
FY25: debt $14.7 B, 1.00× equity
- Total debt $14.7 B
| Quarter | Total debt |
|---|---|
| FY21 | $23.4 B |
| FY22 | $19.5 B |
| FY23 | $18.4 B |
| FY24 | $14.3 B |
| FY25 | $14.7 B |
Debt-to-equity
- Debt-to-equity 1.00×
| Quarter | Debt-to-equity |
|---|---|
| FY21 | 1.14× |
| FY22 | 0.93× |
| FY23 | 0.90× |
| FY24 | 0.77× |
| FY25 | 1.00× |
Jun 2026: debt $13.6 B, debt-to-equity 0.96
- Total debt (quarterly) $13.6 B
| Quarter | Total debt (quarterly) |
|---|---|
| Sep 2023 | $18.6 B |
| Dec 2023 | $18.4 B |
| Mar 2024 | $18.2 B |
| Jun 2024 | $17.4 B |
| Sep 2024 | $16.0 B |
| Dec 2024 | $14.3 B |
| Mar 2025 | $14.5 B |
| Jun 2025 | $14.8 B |
| Sep 2025 | $14.8 B |
| Dec 2025 | $14.7 B |
| Mar 2026 | $14.6 B |
| Jun 2026 | $13.6 B |
Debt-to-equity
- Debt-to-equity 0.96×
| Quarter | Debt-to-equity |
|---|---|
| Sep 2023 | 0.89× |
| Dec 2023 | 0.90× |
| Mar 2024 | 0.91× |
| Jun 2024 | 0.89× |
| Sep 2024 | 0.81× |
| Dec 2024 | 0.77× |
| Mar 2025 | 0.92× |
| Jun 2025 | 0.95× |
| Sep 2025 | 0.97× |
| Dec 2025 | 1.00× |
| Mar 2026 | 1.00× |
| Jun 2026 | 0.96× |
What is the Viatris shareholding pattern?
3.3% of Viatris Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 4.1 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.
There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.
It is a single reading at one point in time; we do not have its history.
Why it is at this level: the figure does not say who has the short positions or why, so we show the level without guessing the story.
How far is Viatris from balance-sheet trouble?
For Viatris Inc., the Z-score is 1.10. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the danger zone. It estimates how far the balance sheet is from trouble; it is not a forecast of failure.
The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.
Why it matters: a Z-score of 1.10 is inside the danger zone, so the balance sheet is a real risk.
How does Viatris rank in its industry?
52.4 out of 100, rank 11 of 28 in Drug Manufacturers - Specialty & Generic, with 64% of the evidence available.
Viatris Inc. scores 52.4 out of 100 against the 28 companies it is compared with in Drug Manufacturers - Specialty & Generic, ranking 11. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
The four parts add up to the total exactly: 18.2 + 8.5 + 11.4 + 14.3 = 52.4. This is the same number shown on the industry page; it is worked out once for the whole group and read here.
What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.
Which companies is Viatris compared with?
Viatris ranks 11 of 28 Drug Manufacturers - Specialty & Generic companies on the 4-Factor Sector Score, with 52.4 out of 100.
- 1Neurocrine Biosciences, Inc.NBIX · turning · Most evidence points up · 81% evidence66.3out of 100
How the score adds up
Growth & earnings 26.1/35 · Revenue 34.4% · Profit 100% · Operating margin change 1 points · 83% evidenceCapital efficiency 18.2/25 · ROCE 19.3% · Operating margin 22.2% · 76% evidenceValuation 13.8/20 · P/E 24× · PEG 0.71 · 65% evidenceRelative strength 8.2/20 · Lead over its industry -5.3% · Lead over S&P 500 6.1% · 1 year 9% · 100% evidence · 0 of 12 weeks aheadExact sum: 26.1 + 18.2 + 13.8 + 8.2 = 66.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 2Indivior Pharmaceuticals, Inc.INDV · quiet · Evidence leans up · 71% evidence63.2out of 100
How the score adds up
Growth & earnings 27.8/35 · Revenue 13.5% · Profit 100% · Operating margin change 23.4 points · 83% evidenceCapital efficiency 20.8/25 · ROCE 152.3% · Operating margin 46.9% · 76% evidenceValuation 10.3/20 · P/E 14.1× · PEG — · 15% evidenceRelative strength 4.3/20 · Lead over its industry -13.9% · Lead over S&P 500 -3.7% · 1 year 15.8% · 100% evidence · 0 of 12 weeks aheadExact sum: 27.8 + 20.8 + 10.3 + 4.3 = 63.2 · What this means: Earnings are strong; relative strength in its sector is -13.9% and the one-year return is 15.8%. - 3Kiniksa Pharmaceuticals International, plcKNSA · leader · Evidence leans up · 71% evidence62.1out of 100
How the score adds up
Growth & earnings 24.1/35 · Revenue 58.7% · Profit 100% · Operating margin change -1.7 points · 83% evidenceCapital efficiency 12.2/25 · ROCE 13.8% · Operating margin 11.2% · 76% evidenceValuation 9.0/20 · P/E 61× · PEG — · 15% evidenceRelative strength 16.8/20 · Lead over its industry 43.2% · Lead over S&P 500 59% · 1 year 150.5% · 100% evidence · 12 of 12 weeks aheadExact sum: 24.1 + 12.2 + 9 + 16.8 = 62.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 4Bausch Health Companies Inc.BHC · leader · Evidence leans up · 71% evidence60.1out of 100
How the score adds up
Growth & earnings 17.9/35 · Revenue 10.1% · Profit -1220.4% · Operating margin change 9.1 points · 83% evidenceCapital efficiency 12.8/25 · ROCE 13.5% · Operating margin 27.2% · 76% evidenceValuation 10.9/20 · P/E -1.7× · PEG — · 15% evidenceRelative strength 18.5/20 · Lead over its industry 17.1% · Lead over S&P 500 30.9% · 1 year 25.4% · 100% evidence · 12 of 12 weeks aheadExact sum: 17.9 + 12.8 + 10.9 + 18.5 = 60.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 5Xeris Biopharma Holdings, Inc.XERS · leader · Evidence leans up · 64% evidence60.0out of 100
How the score adds up
Growth & earnings 21.1/35 · Revenue 36.2% · Profit — · Operating margin change -0.7 points · 62% evidenceCapital efficiency 11.8/25 · ROCE 16.5% · Operating margin 5.6% · 76% evidenceValuation 8.7/20 · P/E 83.3× · PEG — · 15% evidenceRelative strength 18.4/20 · Lead over its industry 18.3% · Lead over S&P 500 31.8% · 1 year 40.8% · 100% evidence · 12 of 12 weeks aheadExact sum: 21.1 + 11.8 + 8.7 + 18.4 = 60 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 6Phibro Animal Health CorporationPAHC · breaking out · Evidence leans up · 81% evidence58.6out of 100
How the score adds up
Growth & earnings 24.4/35 · Revenue 17.2% · Profit 100% · Operating margin change 0.3 points · 83% evidenceCapital efficiency 15.3/25 · ROCE 16.4% · Operating margin 10.6% · 76% evidenceValuation 11.8/20 · P/E 12.8× · PEG 1.44 · 65% evidenceRelative strength 7.1/20 · Lead over its industry -19.8% · Lead over S&P 500 -10.4% · 1 year -9.9% · 100% evidence · 11 of 12 weeks aheadExact sum: 24.4 + 15.3 + 11.8 + 7.1 = 58.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 7Amneal Pharmaceuticals, Inc.AMRX · leader · Evidence leans up · 71% evidence58.6out of 100
How the score adds up
Growth & earnings 21.4/35 · Revenue 9.3% · Profit 100% · Operating margin change 2.8 points · 83% evidenceCapital efficiency 15.1/25 · ROCE 17.1% · Operating margin 18.3% · 76% evidenceValuation 9.3/20 · P/E 35.1× · PEG — · 15% evidenceRelative strength 12.8/20 · Lead over its industry 11.3% · Lead over S&P 500 23.9% · 1 year 75.5% · 100% evidence · 10 of 12 weeks aheadExact sum: 21.4 + 15.1 + 9.3 + 12.8 = 58.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 8BioCryst Pharmaceuticals, Inc.BCRX · quiet · Evidence leans up · 64% evidence58.3out of 100
How the score adds up
Growth & earnings 25.6/35 · Revenue 68.5% · Profit — · Operating margin change 26.9 points · 62% evidenceCapital efficiency 18.1/25 · ROCE 112% · Operating margin 45.1% · 76% evidenceValuation 11.0/20 · P/E -6.6× · PEG — · 15% evidenceRelative strength 3.6/20 · Lead over its industry -18% · Lead over S&P 500 -8.4% · 1 year 16.2% · 100% evidence · 3 of 12 weeks aheadExact sum: 25.6 + 18.1 + 11 + 3.6 = 58.3 · What this means: Earnings are strong; relative strength in its sector is -18% and the one-year return is 16.2%. - 9Liquidia CorporationLQDA · quiet · Evidence leans up · 64% evidence55.8out of 100
How the score adds up
Growth & earnings 26.0/35 · Revenue 100% · Profit — · Operating margin change 474.2 points · 62% evidenceCapital efficiency 17.9/25 · ROCE 50.7% · Operating margin 49.8% · 76% evidenceValuation 9.2/20 · P/E 51.2× · PEG — · 15% evidenceRelative strength 2.7/20 · Lead over its industry -19.6% · Lead over S&P 500 -10.2% · 1 year 81.6% · 100% evidence · 3 of 12 weeks aheadExact sum: 26 + 17.9 + 9.2 + 2.7 = 55.8 · What this means: Earnings are strong; relative strength in its sector is -19.6% and the one-year return is 81.6%. - 10United Therapeutics CorporationUTHR · turning · Evidence leans up · 81% evidence55.4out of 100
How the score adds up
Growth & earnings 14.5/35 · Revenue 2.5% · Profit 5.6% · Operating margin change -6.2 points · 83% evidenceCapital efficiency 20.3/25 · ROCE 21.2% · Operating margin 42.2% · 76% evidenceValuation 9.2/20 · P/E 17.5× · PEG 1.92 · 65% evidenceRelative strength 11.4/20 · Lead over its industry -2.5% · Lead over S&P 500 8.9% · 1 year 35.5% · 100% evidence · 3 of 12 weeks aheadExact sum: 14.5 + 20.3 + 9.2 + 11.4 = 55.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 11Viatris Inc. this pageVTRS · breaking out · Evidence leans up · 64% evidence52.4out of 100
How the score adds up
Growth & earnings 18.2/35 · Revenue 4.4% · Profit — · Operating margin change 3.1 points · 62% evidenceCapital efficiency 8.5/25 · ROCE 4.9% · Operating margin 12.6% · 76% evidenceValuation 11.4/20 · P/E -52.5× · PEG — · 15% evidenceRelative strength 14.3/20 · Lead over its industry 7.3% · Lead over S&P 500 19.5% · 1 year 89.9% · 100% evidence · 5 of 12 weeks aheadExact sum: 18.2 + 8.5 + 11.4 + 14.3 = 52.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 12Trulieve Cannabis Corp.TRLV · breaking out · Evidence leans up · 64% evidence50.8out of 100
- 13Pacira BioSciences, Inc.PCRX · breaking out · Evidence leans up · 64% evidence50.3out of 100
- 14ANI Pharmaceuticals, Inc.ANIP · basing · Evidence leans down · 64% evidence48.3out of 100
- 15Zoetis Inc.ZTS · turning · Evidence leans down · 81% evidence47.1out of 100
- 16Teva Pharmaceutical Industries LimitedTEVA · leader · Evidence leans down · 64% evidence46.9out of 100
- 17Haleon plcHLN · basing · Too little evidence to rank firmly · 56% evidence46.2out of 100
- 18Perrigo Company plcPRGO · breaking out · Evidence leans down · 64% evidence45.1out of 100
- 19Elanco Animal Health IncorporatedELAN · turning · Evidence leans down · 71% evidence44.9out of 100
- 20Lantheus Holdings, Inc.LNTH · turning · Evidence leans down · 81% evidence43.8out of 100
- 21Alkermes plcALKS · quiet · Evidence leans down · 81% evidence43.6out of 100
- 22HUTCHMED (China) LimitedHCM · breaking out · Too little evidence to rank firmly · 51% evidence40.8out of 100
- 23Prestige Consumer Healthcare Inc.PBH · basing · Evidence leans down · 71% evidence37.8out of 100
- 24AlvotechALVO · breaking out · Most evidence points down · 71% evidence33.7out of 100
- 25Hims & Hers Health, Inc.HIMS · quiet · Most evidence points down · 71% evidence27.4out of 100
- 26Supernus Pharmaceuticals, Inc.SUPN · quiet · Most evidence points down · 71% evidence26.6out of 100
- 27Amylyx Pharmaceuticals, Inc.AMLX · leader · Too little evidence to rank firmly · 40% evidence47.7out of 100
- 28Regencell Bioscience Holdings LimitedRGC · losing its lead · Too little evidence to rank firmly · 47% evidence30.6out of 100
Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.
The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.
Related companies: Drug Manufacturers - Specialty & Generic, all 28 compared on one page.
Which companies are close to Viatris in size?
Viatris is the 6th largest of 51 Drug Manufacturers - Specialty & Generic companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: Haleon plc, Zoetis Inc. and United Therapeutics Corporation. Just below it: Neurocrine Biosciences, Inc., Elanco Animal Health Incorporated and Dr. Reddy's Laboratories.
Drug Manufacturers - Specialty & Generic companies close in size
- Haleon plc $41.9 billion
- Zoetis Inc. $36.8 billion
- United Therapeutics Corporation $26.1 billion
- Viatris Inc. $22.1 billion
- Neurocrine Biosciences, Inc. $16.8 billion
- Elanco Animal Health Incorporated $12.6 billion
- Dr. Reddy's Laboratories Limited $12.1 billion
All 51 Drug Manufacturers - Specialty & Generic companies, largest first
Companies close in size in other industries
- CMS Energy Corporation $22.3 billion · Utilities - Regulated Electric
- GLOBALFOUNDRIES Inc. $22.1 billion · Semiconductors
- Viatris Inc. $22.1 billion
- Lennar Corporation $21.9 billion · Residential Construction
- XPO, Inc. $21.9 billion · Trucking
What else do people ask about Viatris?
What were Viatris's latest quarterly results?
Viatris Inc. reported revenue of $3.8 B and a net loss of $119 M for the Jun 2026 quarter. Earnings per share were −$0.10. The operating margin was 12.6%, 3.1 percentage points higher than a year earlier (as of 4 November 2026).
What is Viatris's market cap?
Viatris Inc.'s market capitalisation is $22.1 B at a stock price of $19.22. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026).
How is Viatris performing?
Viatris Inc.'s share price has been rising for 38 weeks. Over the past 13 weeks it has done better than the S&P 500, for 8 weeks running. This describes what the data did, not a rating (as of 4 November 2026).
Will Viatris's stock price go up?
This page does not forecast Viatris Inc.'s stock price. What it shows instead: the stock price is $19.22, and it has been rising for 38 weeks. Its P/E of 304.4× is higher than 93% of its own last 2 years (as of 4 November 2026).
Is Viatris's profit real cash?
Yes, over the last 2 years, 277% of Viatris Inc.'s reported profit came in as cash from operations. The latest year was lower at -66%, so the trend is worth watching. In FY25, operating cash was $2.3 B against reported profit of −$3.5 B.
Most of that cash then goes into building new capacity. These are yearly figures (as of 4 November 2026).
Where is Viatris in its business cycle?
Viatris Inc.'s FY25 operating margin was 8.6%, against a 5-year range of 6.1% to 16.9%: the low end of its own range, which is often where recoveries start. The latest quarter was 12.6%.
Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026).
What could break the Viatris story?
The main question: results are strong, and the P/E is higher than 93% of its own history. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026).
Is Viatris a stock worth studying right now?
What the numbers show: Viatris Inc.'s results are improving, and its P/E is near the top of its own history, higher than 93% of past readings. The main open question: whether earnings grow enough to match the multiple.
Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026).
Where do these numbers come from?
Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.
Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.
See the plain-text version of this page.
More lists
Every Sector Alpha list, grouped
Stock screens
Market lists
Themes
Sectors
US stocks
X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.